[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"$fkz6RsB3DbqzcRoCUEtpMRY9gQOuq2UbWXIC-gQkpKjk":3},{"sponsor":4,"sponsorVariants":5,"totalTrials":6,"truncated":7,"activeTrials":8,"phase3Count":9,"totalEnrollment":10,"activePrograms":11,"nonDrugCount":12,"topConditions":13,"upcomingReadouts":33,"phaseBuckets":54,"rows":61},"Hannover Medical School",[4],197,false,26,17,88049,4,140,[14,17,20,22,24,27,29,31],{"name":15,"count":16},"Lung Transplantation",16,{"name":18,"count":19},"Heart Failure",5,{"name":21,"count":11},"Liver Cirrhosis",{"name":23,"count":11},"Heart Transplantation",{"name":25,"count":26},"Acute Myeloid Leukemia",3,{"name":28,"count":26},"Complication of Surgical Procedure",{"name":30,"count":26},"Anemia, Iron Deficiency",{"name":32,"count":26},"Hypertension",[34,39,44,49],{"nctId":35,"briefTitle":36,"date":37,"intervention":38},"NCT04863703","Improvement of Portal Hypertension During Viral Suppression in Patients With Hepatitis Delta (IMPHROVE-D)","2024-11-30","Bulevirtide",{"nctId":40,"briefTitle":41,"date":42,"intervention":43},"NCT06545175","Intracochlear Application of VSF1.01 for the Reduction of Cochlear Implant Surgery Related Trauma","2026-06","Intracochlear application of VSF1.01",{"nctId":45,"briefTitle":46,"date":47,"intervention":48},"NCT06391450","Study of Empagliflozin in Patients With Autosomal Dominant Polycystic Kidney Disease (EMPA-PKD)","2027-05","Empagliflozin 10 MG",{"nctId":50,"briefTitle":51,"date":52,"intervention":53},"NCT06990087","T-cell Therapy in Patients With PML","2027-11","Application of T-lymphocytes",[55,56,57,58,59,60],"EARLY_PHASE1","PHASE1","PHASE2","PHASE3","PHASE4","NA",[62,86,108,129,152,198,239,261,287,305,329,347,365,390,420,438,463,487,513,539,591,613,635,671,689,707,725,743,769,793,811,835,859,885,911,936,960,1084,1102,1120,1138,1156,1174,1192,1210,1228,1246,1264,1282,1300,1318,1336,1354,1372,1390,1408,1426,1444,1462,1480,1498,1516,1534,1552,1570,1588,1606,1624,1642,1660,1678,1696,1714,1732,1750,1768,1786,1804,1822,1840,1858,1876,1894,1912,1930,1948,1966,1984,2002,2020,2038,2056,2074,2092,2110,2128,2146,2164,2182,2200,2218,2236,2254,2272,2290,2308,2326,2344,2362,2380,2398,2416,2434,2452,2470,2488,2506,2524,2542,2560,2578,2596,2614,2632,2650,2668,2686,2704,2722,2740,2758,2776,2794,2812,2837,2862,2880,2904,2931,2949,2975,2993,3019,3042,3060,3085,3103,3127,3150,3168,3186,3204,3222,3240,3258,3276,3294,3312,3338,3364,3390,3408,3435,3459,3483,3514,3536,3562,3587,3605,3631,3656,3680,3705,3729,3757],{"intervention":48,"totalTrials":63,"cells":64},1,{"EARLY_PHASE1":65,"PHASE1":68,"PHASE2":70,"PHASE3":72,"PHASE4":74,"NA":84},{"trials":66,"activeCount":67},[],0,{"trials":69,"activeCount":67},[],{"trials":71,"activeCount":67},[],{"trials":73,"activeCount":67},[],{"trials":75,"activeCount":63,"soonestReadout":47},[76],{"nctId":45,"briefTitle":46,"status":77,"phases":78,"primaryCompletion":47,"completion":47,"start":79,"enrollment":80,"conditions":81,"interventions":83},"ACTIVE_NOT_RECRUITING",[59],"2024-06-14",44,[82],"Autosomal Dominant Polycystic Kidney",[48],{"trials":85,"activeCount":67},[],{"intervention":53,"totalTrials":63,"cells":87},{"EARLY_PHASE1":88,"PHASE1":90,"PHASE2":92,"PHASE3":102,"PHASE4":104,"NA":106},{"trials":89,"activeCount":67},[],{"trials":91,"activeCount":67},[],{"trials":93,"activeCount":63,"soonestReadout":52},[94],{"nctId":50,"briefTitle":51,"status":95,"phases":96,"primaryCompletion":52,"completion":52,"start":97,"enrollment":98,"conditions":99,"interventions":101},"RECRUITING",[57],"2026-02-06",23,[100],"Progressive Multifocal Leucoencephalopathy (PML)",[53],{"trials":103,"activeCount":67},[],{"trials":105,"activeCount":67},[],{"trials":107,"activeCount":67},[],{"intervention":43,"totalTrials":63,"cells":109},{"EARLY_PHASE1":110,"PHASE1":112,"PHASE2":114,"PHASE3":123,"PHASE4":125,"NA":127},{"trials":111,"activeCount":67},[],{"trials":113,"activeCount":67},[],{"trials":115,"activeCount":63,"soonestReadout":42},[116],{"nctId":40,"briefTitle":41,"status":95,"phases":117,"primaryCompletion":42,"completion":42,"start":118,"enrollment":119,"conditions":120,"interventions":122},[56,57],"2024-11-18",11,[121],"Hearing Loss",[43],{"trials":124,"activeCount":67},[],{"trials":126,"activeCount":67},[],{"trials":128,"activeCount":67},[],{"intervention":38,"totalTrials":63,"cells":130},{"EARLY_PHASE1":131,"PHASE1":133,"PHASE2":135,"PHASE3":137,"PHASE4":139,"NA":141},{"trials":132,"activeCount":67},[],{"trials":134,"activeCount":67},[],{"trials":136,"activeCount":67},[],{"trials":138,"activeCount":67},[],{"trials":140,"activeCount":67},[],{"trials":142,"activeCount":63,"soonestReadout":37},[143],{"nctId":35,"briefTitle":36,"status":77,"phases":144,"primaryCompletion":37,"completion":145,"start":146,"enrollment":119,"conditions":147,"interventions":151},[],"2026-12-31","2021-05-07",[148,149,150,21],"Hepatitis D","Hepatitis B","Portal Hypertension",[38],{"intervention":153,"totalTrials":26,"cells":154},"Ferric maltol 30 mg",{"EARLY_PHASE1":155,"PHASE1":157,"PHASE2":159,"PHASE3":161,"PHASE4":174,"NA":196},{"trials":156,"activeCount":67},[],{"trials":158,"activeCount":67},[],{"trials":160,"activeCount":67},[],{"trials":162,"activeCount":67},[163],{"nctId":164,"briefTitle":165,"status":166,"phases":167,"primaryCompletion":168,"completion":168,"start":169,"enrollment":170,"conditions":171,"interventions":173},"NCT03371173","ORal IrON Supplementation With Ferric Maltol in Patients With Pulmonary Hypertension (ORION-PH-1)","TERMINATED",[58],"2020-03-19","2018-03-27",22,[172,30],"Hypertension, Pulmonary",[153],{"trials":175,"activeCount":67},[176,187],{"nctId":177,"briefTitle":178,"status":179,"phases":180,"primaryCompletion":181,"completion":181,"start":182,"enrollment":183,"conditions":184,"interventions":186},"NCT05697211","ORal IrON Supplementation with Ferric Maltol in Treating Iron Deficiency and Anaemia in Patients with Heart Failure (ORION-HF)","COMPLETED",[59],"2025-01-08","2023-02-21",50,[185,30],"Heart Failure, Left-sided",[153],{"nctId":188,"briefTitle":189,"status":166,"phases":190,"primaryCompletion":191,"completion":191,"start":192,"enrollment":119,"conditions":193,"interventions":195},"NCT03774615","ORal IrON Supplementation With Ferric Maltol in Patients With Heart Failure Carrying Left Ventricular Assist Devices",[59],"2019-11-29","2019-03-18",[194,30],"Heart Failure, Left Sided",[153],{"trials":197,"activeCount":67},[],{"intervention":199,"totalTrials":200,"cells":201},"Empagliflozin",2,{"EARLY_PHASE1":202,"PHASE1":204,"PHASE2":206,"PHASE3":208,"PHASE4":210,"NA":237},{"trials":203,"activeCount":67},[],{"trials":205,"activeCount":67},[],{"trials":207,"activeCount":67},[],{"trials":209,"activeCount":67},[],{"trials":211,"activeCount":67},[212,226],{"nctId":213,"briefTitle":214,"status":166,"phases":215,"primaryCompletion":216,"completion":217,"start":218,"enrollment":219,"conditions":220,"interventions":222},"NCT02985242","Empagliflozin Reduces Progression of Diabetic Retinopathy in Patients With High Risk of Diabetic Macular Edema",[59],"2018-08-01","2018-08-16","2017-06-12",6,[221],"Diabetes Mellitus, Type II",[199,223,224,225],"Glimepiride","Empagliflozin placebo","Glimepiride placebo",{"nctId":227,"briefTitle":228,"status":166,"phases":229,"primaryCompletion":230,"completion":231,"start":232,"enrollment":233,"conditions":234,"interventions":236},"NCT02728453","SGLT2 Inhibition and Left Ventricular Mass",[59],"2017-09-25","2017-09-27","2016-04-27",7,[235],"Diabetes Mellitus Type 2",[199,223],{"trials":238,"activeCount":67},[],{"intervention":223,"totalTrials":200,"cells":240},{"EARLY_PHASE1":241,"PHASE1":243,"PHASE2":245,"PHASE3":247,"PHASE4":249,"NA":259},{"trials":242,"activeCount":67},[],{"trials":244,"activeCount":67},[],{"trials":246,"activeCount":67},[],{"trials":248,"activeCount":67},[],{"trials":250,"activeCount":67},[251,255],{"nctId":213,"briefTitle":214,"status":166,"phases":252,"primaryCompletion":216,"completion":217,"start":218,"enrollment":219,"conditions":253,"interventions":254},[59],[221],[199,223,224,225],{"nctId":227,"briefTitle":228,"status":166,"phases":256,"primaryCompletion":230,"completion":231,"start":232,"enrollment":233,"conditions":257,"interventions":258},[59],[235],[199,223],{"trials":260,"activeCount":67},[],{"intervention":262,"totalTrials":63,"cells":263},"Daptomycin",{"EARLY_PHASE1":264,"PHASE1":266,"PHASE2":268,"PHASE3":270,"PHASE4":272,"NA":285},{"trials":265,"activeCount":67},[],{"trials":267,"activeCount":67},[],{"trials":269,"activeCount":67},[],{"trials":271,"activeCount":67},[],{"trials":273,"activeCount":67},[274],{"nctId":275,"briefTitle":276,"status":179,"phases":277,"primaryCompletion":278,"completion":278,"start":279,"enrollment":280,"conditions":281,"interventions":283},"NCT01080963","Daptomycin as Antibiotic Prophylaxis of Sternal Wound Infections",[59],"2012-03","2008-11",650,[282],"Wound Infection",[262,284],"Cefuroxime",{"trials":286,"activeCount":67},[],{"intervention":284,"totalTrials":63,"cells":288},{"EARLY_PHASE1":289,"PHASE1":291,"PHASE2":293,"PHASE3":295,"PHASE4":297,"NA":303},{"trials":290,"activeCount":67},[],{"trials":292,"activeCount":67},[],{"trials":294,"activeCount":67},[],{"trials":296,"activeCount":67},[],{"trials":298,"activeCount":67},[299],{"nctId":275,"briefTitle":276,"status":179,"phases":300,"primaryCompletion":278,"completion":278,"start":279,"enrollment":280,"conditions":301,"interventions":302},[59],[282],[262,284],{"trials":304,"activeCount":67},[],{"intervention":306,"totalTrials":63,"cells":307},"OBV\u002FPTV\u002Fr and DSV",{"EARLY_PHASE1":308,"PHASE1":310,"PHASE2":312,"PHASE3":314,"PHASE4":316,"NA":327},{"trials":309,"activeCount":67},[],{"trials":311,"activeCount":67},[],{"trials":313,"activeCount":67},[],{"trials":315,"activeCount":67},[],{"trials":317,"activeCount":67},[318],{"nctId":319,"briefTitle":320,"status":166,"phases":321,"primaryCompletion":322,"completion":322,"start":323,"enrollment":19,"conditions":324,"interventions":326},"NCT03003338","MHH-HCV-NPM-Neuropsychiatric Manifestations of HCV-infection During and After Treatment With OBV\u002FPTV\u002Fr and DSV",[59],"2018-10-22","2017-10-24",[325],"Hepatitis C, Chronic",[306],{"trials":328,"activeCount":67},[],{"intervention":224,"totalTrials":63,"cells":330},{"EARLY_PHASE1":331,"PHASE1":333,"PHASE2":335,"PHASE3":337,"PHASE4":339,"NA":345},{"trials":332,"activeCount":67},[],{"trials":334,"activeCount":67},[],{"trials":336,"activeCount":67},[],{"trials":338,"activeCount":67},[],{"trials":340,"activeCount":67},[341],{"nctId":213,"briefTitle":214,"status":166,"phases":342,"primaryCompletion":216,"completion":217,"start":218,"enrollment":219,"conditions":343,"interventions":344},[59],[221],[199,223,224,225],{"trials":346,"activeCount":67},[],{"intervention":225,"totalTrials":63,"cells":348},{"EARLY_PHASE1":349,"PHASE1":351,"PHASE2":353,"PHASE3":355,"PHASE4":357,"NA":363},{"trials":350,"activeCount":67},[],{"trials":352,"activeCount":67},[],{"trials":354,"activeCount":67},[],{"trials":356,"activeCount":67},[],{"trials":358,"activeCount":67},[359],{"nctId":213,"briefTitle":214,"status":166,"phases":360,"primaryCompletion":216,"completion":217,"start":218,"enrollment":219,"conditions":361,"interventions":362},[59],[221],[199,223,224,225],{"trials":364,"activeCount":67},[],{"intervention":366,"totalTrials":63,"cells":367},"Extended-Release Niacin",{"EARLY_PHASE1":368,"PHASE1":370,"PHASE2":372,"PHASE3":374,"PHASE4":376,"NA":388},{"trials":369,"activeCount":67},[],{"trials":371,"activeCount":67},[],{"trials":373,"activeCount":67},[],{"trials":375,"activeCount":67},[],{"trials":377,"activeCount":67},[378],{"nctId":379,"briefTitle":380,"status":179,"phases":381,"completion":382,"start":383,"enrollment":384,"conditions":385,"interventions":387},"NCT00346970","The High Density Lipoprotein and Endothelial Function, Niacin and Nitric Oxide Study (The High-Ennd Study)",[59],"2007-07","2006-07",32,[386],"Metabolic Syndrome",[366],{"trials":389,"activeCount":67},[],{"intervention":391,"totalTrials":63,"cells":392},"mTOR inhibitor",{"EARLY_PHASE1":393,"PHASE1":395,"PHASE2":397,"PHASE3":399,"PHASE4":401,"NA":418},{"trials":394,"activeCount":67},[],{"trials":396,"activeCount":67},[],{"trials":398,"activeCount":67},[],{"trials":400,"activeCount":67},[],{"trials":402,"activeCount":67},[403],{"nctId":404,"briefTitle":405,"status":406,"phases":407,"primaryCompletion":408,"completion":409,"start":410,"enrollment":411,"conditions":412,"interventions":416},"NCT01289301","Studying the Effect of Changing Immunosuppression in Case of Polyoma BK Virus Infection of the Renal Transplant","UNKNOWN",[59],"2017-10","2018-10","2011-10",124,[413,414,415],"Disorder Related to Renal Transplantation","Immunosuppression Related Infectious Disease","Virus Diseases",[391,417],"cyclosporine or tacrolimus",{"trials":419,"activeCount":67},[],{"intervention":417,"totalTrials":63,"cells":421},{"EARLY_PHASE1":422,"PHASE1":424,"PHASE2":426,"PHASE3":428,"PHASE4":430,"NA":436},{"trials":423,"activeCount":67},[],{"trials":425,"activeCount":67},[],{"trials":427,"activeCount":67},[],{"trials":429,"activeCount":67},[],{"trials":431,"activeCount":67},[432],{"nctId":404,"briefTitle":405,"status":406,"phases":433,"primaryCompletion":408,"completion":409,"start":410,"enrollment":411,"conditions":434,"interventions":435},[59],[413,414,415],[391,417],{"trials":437,"activeCount":67},[],{"intervention":439,"totalTrials":63,"cells":440},"L-arginine",{"EARLY_PHASE1":441,"PHASE1":443,"PHASE2":445,"PHASE3":447,"PHASE4":449,"NA":461},{"trials":442,"activeCount":67},[],{"trials":444,"activeCount":67},[],{"trials":446,"activeCount":67},[],{"trials":448,"activeCount":67},[],{"trials":450,"activeCount":67},[451],{"nctId":452,"briefTitle":453,"status":179,"phases":454,"completion":455,"start":456,"enrollment":457,"conditions":458,"interventions":460},"NCT00777075","L-Arginine and Erectile Dysfunction",[59],"2005-11","2003-07",57,[459],"Erectile Dysfunction",[439],{"trials":462,"activeCount":67},[],{"intervention":464,"totalTrials":63,"cells":465},"Aerosolized iloprost",{"EARLY_PHASE1":466,"PHASE1":468,"PHASE2":470,"PHASE3":472,"PHASE4":474,"NA":485},{"trials":467,"activeCount":67},[],{"trials":469,"activeCount":67},[],{"trials":471,"activeCount":67},[],{"trials":473,"activeCount":67},[],{"trials":475,"activeCount":67},[476],{"nctId":477,"briefTitle":478,"status":166,"phases":479,"primaryCompletion":480,"completion":480,"start":481,"enrollment":482,"conditions":483,"interventions":484},"NCT00120380","Combination Therapy of Bosentan and Aerosolized Iloprost in Idiopathic Pulmonary Arterial Hypertension (IPAH)",[59],"2006-05","2004-09",40,[32],[464],{"trials":486,"activeCount":67},[],{"intervention":488,"totalTrials":63,"cells":489},"Sultamicillin",{"EARLY_PHASE1":490,"PHASE1":492,"PHASE2":494,"PHASE3":496,"PHASE4":498,"NA":511},{"trials":491,"activeCount":67},[],{"trials":493,"activeCount":67},[],{"trials":495,"activeCount":67},[],{"trials":497,"activeCount":67},[],{"trials":499,"activeCount":67},[500],{"nctId":501,"briefTitle":502,"status":179,"phases":503,"primaryCompletion":504,"completion":505,"start":506,"enrollment":507,"conditions":508,"interventions":510},"NCT01892488","Study to Demonstrate That Antibiotics Are Not Needed in Moderate Acute Exacerbations of COPD",[59],"2019-04-23","2019-06-05","2013-06-07",295,[509],"Chronic Obstructive Pulmonary Disease (COPD)",[488],{"trials":512,"activeCount":67},[],{"intervention":514,"totalTrials":63,"cells":515},"Sitagliptin",{"EARLY_PHASE1":516,"PHASE1":518,"PHASE2":520,"PHASE3":522,"PHASE4":524,"NA":537},{"trials":517,"activeCount":67},[],{"trials":519,"activeCount":67},[],{"trials":521,"activeCount":67},[],{"trials":523,"activeCount":67},[],{"trials":525,"activeCount":67},[526],{"nctId":527,"briefTitle":528,"status":406,"phases":529,"primaryCompletion":530,"completion":531,"start":532,"enrollment":533,"conditions":534,"interventions":536},"NCT01096277","Vascular Effects of Sitagliptin in Diabetes Mellitus",[59],"2011-11","2012-12","2010-10",70,[535],"Type 2 Diabetes Mellitus",[514],{"trials":538,"activeCount":67},[],{"intervention":540,"totalTrials":200,"cells":541},"Cytarabine",{"EARLY_PHASE1":542,"PHASE1":544,"PHASE2":546,"PHASE3":568,"PHASE4":587,"NA":589},{"trials":543,"activeCount":67},[],{"trials":545,"activeCount":67},[],{"trials":547,"activeCount":67},[548],{"nctId":549,"briefTitle":550,"status":406,"phases":551,"start":552,"conditions":553,"interventions":555},"NCT00002532","Combination Chemotherapy in Treating Patients With Relapsed or Refractory Acute Lymphocytic Leukemia",[57],"1993-01",[554],"Leukemia",[556,557,558,559,560,561,562,563,564,565,566,567],"filgrastim","asparaginase","cytarabine","daunorubicin hydrochloride","dexamethasone","etoposide","idarubicin","ifosfamide","leucovorin calcium","methotrexate","prednisolone","vindesine",{"trials":569,"activeCount":67},[570],{"nctId":571,"briefTitle":572,"status":406,"phases":573,"completion":574,"start":575,"enrollment":576,"conditions":577,"interventions":581},"NCT00209833","Treatment of Adults Aged Up to 60 Years With De Novo Acute Myeloblastic Leukaemia,Secondary AML, or RAEB-T",[57,58],"2005-09","1999-01",200,[578,579,580],"De Novo Akute Myeloid Leukemia (AML)","Secondary Acute Myeloid Leukemia (AML)","Refractory Anemia With Excess of Blasts in Transformation",[540,582,583,584,585,586],"Idarubicin","Etoposide","Fludarabine","G-CSF","Daunorubicine",{"trials":588,"activeCount":67},[],{"trials":590,"activeCount":67},[],{"intervention":582,"totalTrials":200,"cells":592},{"EARLY_PHASE1":593,"PHASE1":595,"PHASE2":597,"PHASE3":603,"PHASE4":609,"NA":611},{"trials":594,"activeCount":67},[],{"trials":596,"activeCount":67},[],{"trials":598,"activeCount":67},[599],{"nctId":549,"briefTitle":550,"status":406,"phases":600,"start":552,"conditions":601,"interventions":602},[57],[554],[556,557,558,559,560,561,562,563,564,565,566,567],{"trials":604,"activeCount":67},[605],{"nctId":571,"briefTitle":572,"status":406,"phases":606,"completion":574,"start":575,"enrollment":576,"conditions":607,"interventions":608},[57,58],[578,579,580],[540,582,583,584,585,586],{"trials":610,"activeCount":67},[],{"trials":612,"activeCount":67},[],{"intervention":583,"totalTrials":200,"cells":614},{"EARLY_PHASE1":615,"PHASE1":617,"PHASE2":619,"PHASE3":625,"PHASE4":631,"NA":633},{"trials":616,"activeCount":67},[],{"trials":618,"activeCount":67},[],{"trials":620,"activeCount":67},[621],{"nctId":549,"briefTitle":550,"status":406,"phases":622,"start":552,"conditions":623,"interventions":624},[57],[554],[556,557,558,559,560,561,562,563,564,565,566,567],{"trials":626,"activeCount":67},[627],{"nctId":571,"briefTitle":572,"status":406,"phases":628,"completion":574,"start":575,"enrollment":576,"conditions":629,"interventions":630},[57,58],[578,579,580],[540,582,583,584,585,586],{"trials":632,"activeCount":67},[],{"trials":634,"activeCount":67},[],{"intervention":636,"totalTrials":200,"cells":637},"Everolimus",{"EARLY_PHASE1":638,"PHASE1":640,"PHASE2":642,"PHASE3":655,"PHASE4":667,"NA":669},{"trials":639,"activeCount":67},[],{"trials":641,"activeCount":67},[],{"trials":643,"activeCount":67},[644],{"nctId":645,"briefTitle":646,"status":179,"phases":647,"primaryCompletion":648,"completion":648,"start":649,"enrollment":650,"conditions":651,"interventions":654},"NCT01242631","Everolimus for Patients With Relapsed\u002FRefractory Germ Cell Cancer",[57],"2014-03","2010-11",25,[652,653],"Testicular Cancer","Germ Cell Cancer",[636],{"trials":656,"activeCount":67},[657],{"nctId":658,"briefTitle":659,"status":179,"phases":660,"primaryCompletion":530,"completion":661,"start":662,"enrollment":663,"conditions":664,"interventions":665},"NCT00402532","Immunosuppressive Therapy With Certican (Everolimus) After Lung Transplantation",[58],"2011-12","2005-03",190,[15],[636,666],"Mycophenolatmofetil",{"trials":668,"activeCount":67},[],{"trials":670,"activeCount":67},[],{"intervention":584,"totalTrials":63,"cells":672},{"EARLY_PHASE1":673,"PHASE1":675,"PHASE2":677,"PHASE3":679,"PHASE4":685,"NA":687},{"trials":674,"activeCount":67},[],{"trials":676,"activeCount":67},[],{"trials":678,"activeCount":67},[],{"trials":680,"activeCount":67},[681],{"nctId":571,"briefTitle":572,"status":406,"phases":682,"completion":574,"start":575,"enrollment":576,"conditions":683,"interventions":684},[57,58],[578,579,580],[540,582,583,584,585,586],{"trials":686,"activeCount":67},[],{"trials":688,"activeCount":67},[],{"intervention":585,"totalTrials":63,"cells":690},{"EARLY_PHASE1":691,"PHASE1":693,"PHASE2":695,"PHASE3":697,"PHASE4":703,"NA":705},{"trials":692,"activeCount":67},[],{"trials":694,"activeCount":67},[],{"trials":696,"activeCount":67},[],{"trials":698,"activeCount":67},[699],{"nctId":571,"briefTitle":572,"status":406,"phases":700,"completion":574,"start":575,"enrollment":576,"conditions":701,"interventions":702},[57,58],[578,579,580],[540,582,583,584,585,586],{"trials":704,"activeCount":67},[],{"trials":706,"activeCount":67},[],{"intervention":586,"totalTrials":63,"cells":708},{"EARLY_PHASE1":709,"PHASE1":711,"PHASE2":713,"PHASE3":715,"PHASE4":721,"NA":723},{"trials":710,"activeCount":67},[],{"trials":712,"activeCount":67},[],{"trials":714,"activeCount":67},[],{"trials":716,"activeCount":67},[717],{"nctId":571,"briefTitle":572,"status":406,"phases":718,"completion":574,"start":575,"enrollment":576,"conditions":719,"interventions":720},[57,58],[578,579,580],[540,582,583,584,585,586],{"trials":722,"activeCount":67},[],{"trials":724,"activeCount":67},[],{"intervention":666,"totalTrials":63,"cells":726},{"EARLY_PHASE1":727,"PHASE1":729,"PHASE2":731,"PHASE3":733,"PHASE4":739,"NA":741},{"trials":728,"activeCount":67},[],{"trials":730,"activeCount":67},[],{"trials":732,"activeCount":67},[],{"trials":734,"activeCount":67},[735],{"nctId":658,"briefTitle":659,"status":179,"phases":736,"primaryCompletion":530,"completion":661,"start":662,"enrollment":663,"conditions":737,"interventions":738},[58],[15],[636,666],{"trials":740,"activeCount":67},[],{"trials":742,"activeCount":67},[],{"intervention":744,"totalTrials":63,"cells":745},"Recombinant erythropoietin alpha",{"EARLY_PHASE1":746,"PHASE1":748,"PHASE2":750,"PHASE3":752,"PHASE4":765,"NA":767},{"trials":747,"activeCount":67},[],{"trials":749,"activeCount":67},[],{"trials":751,"activeCount":67},[],{"trials":753,"activeCount":67},[754],{"nctId":755,"briefTitle":756,"status":179,"phases":757,"primaryCompletion":758,"completion":759,"start":760,"enrollment":761,"conditions":762,"interventions":764},"NCT00425698","Erythropoietin (EPO) and Ischemia-reperfusion After Kidney Transplantation",[57,58],"2009-05","2009-11","2007-02",88,[763],"Kidney Transplantation",[744],{"trials":766,"activeCount":67},[],{"trials":768,"activeCount":67},[],{"intervention":770,"totalTrials":63,"cells":771},"Advagraf®",{"EARLY_PHASE1":772,"PHASE1":774,"PHASE2":776,"PHASE3":778,"PHASE4":789,"NA":791},{"trials":773,"activeCount":67},[],{"trials":775,"activeCount":67},[],{"trials":777,"activeCount":67},[],{"trials":779,"activeCount":67},[780],{"nctId":781,"briefTitle":782,"status":166,"phases":783,"primaryCompletion":784,"completion":784,"start":785,"enrollment":650,"conditions":786,"interventions":787},"NCT00930241","Twice Daily Versus Once Daily Administration of the Tacrolimus in Lung Transplantation",[58],"2012-07","2009-07",[15],[770,788],"Prograf®",{"trials":790,"activeCount":67},[],{"trials":792,"activeCount":67},[],{"intervention":788,"totalTrials":63,"cells":794},{"EARLY_PHASE1":795,"PHASE1":797,"PHASE2":799,"PHASE3":801,"PHASE4":807,"NA":809},{"trials":796,"activeCount":67},[],{"trials":798,"activeCount":67},[],{"trials":800,"activeCount":67},[],{"trials":802,"activeCount":67},[803],{"nctId":781,"briefTitle":782,"status":166,"phases":804,"primaryCompletion":784,"completion":784,"start":785,"enrollment":650,"conditions":805,"interventions":806},[58],[15],[770,788],{"trials":808,"activeCount":67},[],{"trials":810,"activeCount":67},[],{"intervention":812,"totalTrials":63,"cells":813},"Enoxaparin",{"EARLY_PHASE1":814,"PHASE1":816,"PHASE2":818,"PHASE3":820,"PHASE4":831,"NA":833},{"trials":815,"activeCount":67},[],{"trials":817,"activeCount":67},[],{"trials":819,"activeCount":67},[],{"trials":821,"activeCount":67},[822],{"nctId":823,"briefTitle":824,"status":166,"phases":825,"primaryCompletion":826,"completion":826,"start":759,"enrollment":827,"conditions":828,"interventions":830},"NCT01058759","Taxotere-Enoxaparin-(ENOXA)-Study",[58],"2011-02",14,[829],"Non-small Cell Lung Cancer",[812],{"trials":832,"activeCount":67},[],{"trials":834,"activeCount":67},[],{"intervention":836,"totalTrials":63,"cells":837},"Cyclophosphamide",{"EARLY_PHASE1":838,"PHASE1":840,"PHASE2":842,"PHASE3":844,"PHASE4":855,"NA":857},{"trials":839,"activeCount":67},[],{"trials":841,"activeCount":67},[],{"trials":843,"activeCount":67},[],{"trials":845,"activeCount":67},[846],{"nctId":847,"briefTitle":848,"status":179,"phases":849,"primaryCompletion":850,"completion":850,"start":760,"enrollment":851,"conditions":852,"interventions":854},"NCT00396682","Elimination of CD4+CD25+ Regulatory T Cells in Patients With Hepatocellular Carcinoma",[58],"2008-12",12,[853],"Advanced HCC",[836],{"trials":856,"activeCount":67},[],{"trials":858,"activeCount":67},[],{"intervention":860,"totalTrials":63,"cells":861},"nabiximols",{"EARLY_PHASE1":862,"PHASE1":864,"PHASE2":866,"PHASE3":868,"PHASE4":881,"NA":883},{"trials":863,"activeCount":67},[],{"trials":865,"activeCount":67},[],{"trials":867,"activeCount":67},[],{"trials":869,"activeCount":67},[870],{"nctId":871,"briefTitle":872,"status":179,"phases":873,"primaryCompletion":874,"completion":874,"start":875,"enrollment":876,"conditions":877,"interventions":880},"NCT03087201","CANNAbinoids in the Treatment of TICS (CANNA-TICS)",[58],"2020-11-20","2018-04-05",98,[878,879],"Tourette Syndrome","Tic Disorders",[860],{"trials":882,"activeCount":67},[],{"trials":884,"activeCount":67},[],{"intervention":886,"totalTrials":63,"cells":887},"Rituximab",{"EARLY_PHASE1":888,"PHASE1":890,"PHASE2":892,"PHASE3":894,"PHASE4":907,"NA":909},{"trials":889,"activeCount":67},[],{"trials":891,"activeCount":67},[],{"trials":893,"activeCount":67},[],{"trials":895,"activeCount":67},[896],{"nctId":897,"briefTitle":898,"status":166,"phases":899,"primaryCompletion":900,"completion":901,"start":902,"enrollment":903,"conditions":904,"interventions":906},"NCT01117662","Efficacy of Rituximab in Acute Cellular Rejection in Renal Transplant Patients",[58],"2016-05","2016-08-23","2012-05",13,[905],"Acute Rejection",[886],{"trials":908,"activeCount":67},[],{"trials":910,"activeCount":67},[],{"intervention":912,"totalTrials":63,"cells":913},"Moxifloxacin\u002FMetronidazole or Piperacillin\u002FTazobactam",{"EARLY_PHASE1":914,"PHASE1":916,"PHASE2":918,"PHASE3":920,"PHASE4":932,"NA":934},{"trials":915,"activeCount":67},[],{"trials":917,"activeCount":67},[],{"trials":919,"activeCount":67},[],{"trials":921,"activeCount":67},[922],{"nctId":923,"briefTitle":924,"status":179,"phases":925,"primaryCompletion":926,"completion":926,"start":927,"enrollment":928,"conditions":929,"interventions":931},"NCT00629135","Moxifloxacin Plus Metronidazole Versus Piperacillin\u002FTazobactam for the Treatment of Patients With Intra-abdominal Abscesses",[58],"2011-08-15","2005-11-15",180,[930],"Abscess, Intra-Abdominal",[912],{"trials":933,"activeCount":67},[],{"trials":935,"activeCount":67},[],{"intervention":937,"totalTrials":63,"cells":938},"Quetiapine XR",{"EARLY_PHASE1":939,"PHASE1":941,"PHASE2":943,"PHASE3":945,"PHASE4":956,"NA":958},{"trials":940,"activeCount":67},[],{"trials":942,"activeCount":67},[],{"trials":944,"activeCount":67},[],{"trials":946,"activeCount":67},[947],{"nctId":948,"briefTitle":949,"status":166,"phases":950,"primaryCompletion":951,"completion":951,"start":952,"enrollment":19,"conditions":953,"interventions":955},"NCT01071135","Quetiapine XR in Schizophrenic Patients",[58],"2010-08","2009-09",[954],"Schizophrenia",[937],{"trials":957,"activeCount":67},[],{"trials":959,"activeCount":67},[],{"intervention":961,"totalTrials":63,"cells":962},"Phenobarbital",{"EARLY_PHASE1":963,"PHASE1":965,"PHASE2":967,"PHASE3":969,"PHASE4":1080,"NA":1082},{"trials":964,"activeCount":67},[],{"trials":966,"activeCount":67},[],{"trials":968,"activeCount":67},[],{"trials":970,"activeCount":67},[971],{"nctId":972,"briefTitle":973,"status":166,"phases":974,"primaryCompletion":975,"completion":975,"start":976,"enrollment":977,"conditions":978,"interventions":983},"NCT02374567","Pharmacovigilance in Gerontopsychiatric Patients",[58],"2017-06-28","2015-01",407,[979,980,954,981,982],"Dementia","Depression","Psychosomatic Disorders","Anxiety Disorders",[961,984,985,986,987,988,989,990,991,992,993,994,995,996,997,998,999,1000,1001,1002,1003,1004,1005,1006,1007,1008,1009,1010,1011,1012,1013,1014,1015,1016,1017,1018,1019,1020,1021,1022,1023,1024,1025,1026,1027,1028,1029,1030,1031,1032,1033,1034,1035,1036,1037,1038,1039,1040,1041,1042,1043,1044,1045,1046,1047,1048,1049,1050,1051,1052,1053,1054,1055,1056,1057,1058,1059,1060,1061,1062,1063,1064,1065,1066,1067,1068,1069,1070,1071,1072,1073,1074,1075,1076,1077,1078,1079],"Phenytoin","Carbamazepine","Oxcarbazepine","Valproic Acid","Lamotrigine","Topiramate","Gabapentin","Levetiracetam","Pregabalin","Lacosamide","Clonazepam","Biperiden","Levomepromazine","Fluphenazine","Perphenazine","Perazine","Thioridazine","Haloperidol","Melperone","Pipamperone","Bromperidol","Benperidol","Sertindole","Ziprasidone","Flupentixol","Chlorprothixene","Zuclopenthixol","Fluspirilene","Pimozide","Clozapine","Olanzapine","Quetiapine","Sulpiride","Tiapride","Amisulpride","Prothipendyl","Risperidone","Aripiprazole","Paliperidone","Diazepam","Oxazepam","Lorazepam","Bromazepam","Clobazam","Alprazolam","Hydroxyzine","Buspirone","Chloral Hydrate","Flurazepam","Nitrazepam","Triazolam","Lormetazepam","Temazepam","Midazolam","Brotizolam","Zopiclone","Zolpidem","Zaleplon","Melatonin","Clomethiazole","Diphenhydramine","Promethazine","Imipramine","Clomipramine","Opipramol","Trimipramine","Amitriptyline","Nortriptyline","Doxepin","Maprotiline","Amitriptyline oxide","Fluoxetine","Citalopram","Paroxetine","Sertraline","Fluvoxamine","Escitalopram","Tranylcypromine","Moclobemide","Mianserin","Trazodone","Mirtazapine","Bupropion","Venlafaxine","Reboxetine","Duloxetine","Agomelatine","Pyritinol","Piracetam","Donepezil","Rivastigmine","Galantamine","Memantine","Nicergoline","Acamprosate","Lithium",{"trials":1081,"activeCount":67},[],{"trials":1083,"activeCount":67},[],{"intervention":984,"totalTrials":63,"cells":1085},{"EARLY_PHASE1":1086,"PHASE1":1088,"PHASE2":1090,"PHASE3":1092,"PHASE4":1098,"NA":1100},{"trials":1087,"activeCount":67},[],{"trials":1089,"activeCount":67},[],{"trials":1091,"activeCount":67},[],{"trials":1093,"activeCount":67},[1094],{"nctId":972,"briefTitle":973,"status":166,"phases":1095,"primaryCompletion":975,"completion":975,"start":976,"enrollment":977,"conditions":1096,"interventions":1097},[58],[979,980,954,981,982],[961,984,985,986,987,988,989,990,991,992,993,994,995,996,997,998,999,1000,1001,1002,1003,1004,1005,1006,1007,1008,1009,1010,1011,1012,1013,1014,1015,1016,1017,1018,1019,1020,1021,1022,1023,1024,1025,1026,1027,1028,1029,1030,1031,1032,1033,1034,1035,1036,1037,1038,1039,1040,1041,1042,1043,1044,1045,1046,1047,1048,1049,1050,1051,1052,1053,1054,1055,1056,1057,1058,1059,1060,1061,1062,1063,1064,1065,1066,1067,1068,1069,1070,1071,1072,1073,1074,1075,1076,1077,1078,1079],{"trials":1099,"activeCount":67},[],{"trials":1101,"activeCount":67},[],{"intervention":985,"totalTrials":63,"cells":1103},{"EARLY_PHASE1":1104,"PHASE1":1106,"PHASE2":1108,"PHASE3":1110,"PHASE4":1116,"NA":1118},{"trials":1105,"activeCount":67},[],{"trials":1107,"activeCount":67},[],{"trials":1109,"activeCount":67},[],{"trials":1111,"activeCount":67},[1112],{"nctId":972,"briefTitle":973,"status":166,"phases":1113,"primaryCompletion":975,"completion":975,"start":976,"enrollment":977,"conditions":1114,"interventions":1115},[58],[979,980,954,981,982],[961,984,985,986,987,988,989,990,991,992,993,994,995,996,997,998,999,1000,1001,1002,1003,1004,1005,1006,1007,1008,1009,1010,1011,1012,1013,1014,1015,1016,1017,1018,1019,1020,1021,1022,1023,1024,1025,1026,1027,1028,1029,1030,1031,1032,1033,1034,1035,1036,1037,1038,1039,1040,1041,1042,1043,1044,1045,1046,1047,1048,1049,1050,1051,1052,1053,1054,1055,1056,1057,1058,1059,1060,1061,1062,1063,1064,1065,1066,1067,1068,1069,1070,1071,1072,1073,1074,1075,1076,1077,1078,1079],{"trials":1117,"activeCount":67},[],{"trials":1119,"activeCount":67},[],{"intervention":986,"totalTrials":63,"cells":1121},{"EARLY_PHASE1":1122,"PHASE1":1124,"PHASE2":1126,"PHASE3":1128,"PHASE4":1134,"NA":1136},{"trials":1123,"activeCount":67},[],{"trials":1125,"activeCount":67},[],{"trials":1127,"activeCount":67},[],{"trials":1129,"activeCount":67},[1130],{"nctId":972,"briefTitle":973,"status":166,"phases":1131,"primaryCompletion":975,"completion":975,"start":976,"enrollment":977,"conditions":1132,"interventions":1133},[58],[979,980,954,981,982],[961,984,985,986,987,988,989,990,991,992,993,994,995,996,997,998,999,1000,1001,1002,1003,1004,1005,1006,1007,1008,1009,1010,1011,1012,1013,1014,1015,1016,1017,1018,1019,1020,1021,1022,1023,1024,1025,1026,1027,1028,1029,1030,1031,1032,1033,1034,1035,1036,1037,1038,1039,1040,1041,1042,1043,1044,1045,1046,1047,1048,1049,1050,1051,1052,1053,1054,1055,1056,1057,1058,1059,1060,1061,1062,1063,1064,1065,1066,1067,1068,1069,1070,1071,1072,1073,1074,1075,1076,1077,1078,1079],{"trials":1135,"activeCount":67},[],{"trials":1137,"activeCount":67},[],{"intervention":987,"totalTrials":63,"cells":1139},{"EARLY_PHASE1":1140,"PHASE1":1142,"PHASE2":1144,"PHASE3":1146,"PHASE4":1152,"NA":1154},{"trials":1141,"activeCount":67},[],{"trials":1143,"activeCount":67},[],{"trials":1145,"activeCount":67},[],{"trials":1147,"activeCount":67},[1148],{"nctId":972,"briefTitle":973,"status":166,"phases":1149,"primaryCompletion":975,"completion":975,"start":976,"enrollment":977,"conditions":1150,"interventions":1151},[58],[979,980,954,981,982],[961,984,985,986,987,988,989,990,991,992,993,994,995,996,997,998,999,1000,1001,1002,1003,1004,1005,1006,1007,1008,1009,1010,1011,1012,1013,1014,1015,1016,1017,1018,1019,1020,1021,1022,1023,1024,1025,1026,1027,1028,1029,1030,1031,1032,1033,1034,1035,1036,1037,1038,1039,1040,1041,1042,1043,1044,1045,1046,1047,1048,1049,1050,1051,1052,1053,1054,1055,1056,1057,1058,1059,1060,1061,1062,1063,1064,1065,1066,1067,1068,1069,1070,1071,1072,1073,1074,1075,1076,1077,1078,1079],{"trials":1153,"activeCount":67},[],{"trials":1155,"activeCount":67},[],{"intervention":988,"totalTrials":63,"cells":1157},{"EARLY_PHASE1":1158,"PHASE1":1160,"PHASE2":1162,"PHASE3":1164,"PHASE4":1170,"NA":1172},{"trials":1159,"activeCount":67},[],{"trials":1161,"activeCount":67},[],{"trials":1163,"activeCount":67},[],{"trials":1165,"activeCount":67},[1166],{"nctId":972,"briefTitle":973,"status":166,"phases":1167,"primaryCompletion":975,"completion":975,"start":976,"enrollment":977,"conditions":1168,"interventions":1169},[58],[979,980,954,981,982],[961,984,985,986,987,988,989,990,991,992,993,994,995,996,997,998,999,1000,1001,1002,1003,1004,1005,1006,1007,1008,1009,1010,1011,1012,1013,1014,1015,1016,1017,1018,1019,1020,1021,1022,1023,1024,1025,1026,1027,1028,1029,1030,1031,1032,1033,1034,1035,1036,1037,1038,1039,1040,1041,1042,1043,1044,1045,1046,1047,1048,1049,1050,1051,1052,1053,1054,1055,1056,1057,1058,1059,1060,1061,1062,1063,1064,1065,1066,1067,1068,1069,1070,1071,1072,1073,1074,1075,1076,1077,1078,1079],{"trials":1171,"activeCount":67},[],{"trials":1173,"activeCount":67},[],{"intervention":989,"totalTrials":63,"cells":1175},{"EARLY_PHASE1":1176,"PHASE1":1178,"PHASE2":1180,"PHASE3":1182,"PHASE4":1188,"NA":1190},{"trials":1177,"activeCount":67},[],{"trials":1179,"activeCount":67},[],{"trials":1181,"activeCount":67},[],{"trials":1183,"activeCount":67},[1184],{"nctId":972,"briefTitle":973,"status":166,"phases":1185,"primaryCompletion":975,"completion":975,"start":976,"enrollment":977,"conditions":1186,"interventions":1187},[58],[979,980,954,981,982],[961,984,985,986,987,988,989,990,991,992,993,994,995,996,997,998,999,1000,1001,1002,1003,1004,1005,1006,1007,1008,1009,1010,1011,1012,1013,1014,1015,1016,1017,1018,1019,1020,1021,1022,1023,1024,1025,1026,1027,1028,1029,1030,1031,1032,1033,1034,1035,1036,1037,1038,1039,1040,1041,1042,1043,1044,1045,1046,1047,1048,1049,1050,1051,1052,1053,1054,1055,1056,1057,1058,1059,1060,1061,1062,1063,1064,1065,1066,1067,1068,1069,1070,1071,1072,1073,1074,1075,1076,1077,1078,1079],{"trials":1189,"activeCount":67},[],{"trials":1191,"activeCount":67},[],{"intervention":990,"totalTrials":63,"cells":1193},{"EARLY_PHASE1":1194,"PHASE1":1196,"PHASE2":1198,"PHASE3":1200,"PHASE4":1206,"NA":1208},{"trials":1195,"activeCount":67},[],{"trials":1197,"activeCount":67},[],{"trials":1199,"activeCount":67},[],{"trials":1201,"activeCount":67},[1202],{"nctId":972,"briefTitle":973,"status":166,"phases":1203,"primaryCompletion":975,"completion":975,"start":976,"enrollment":977,"conditions":1204,"interventions":1205},[58],[979,980,954,981,982],[961,984,985,986,987,988,989,990,991,992,993,994,995,996,997,998,999,1000,1001,1002,1003,1004,1005,1006,1007,1008,1009,1010,1011,1012,1013,1014,1015,1016,1017,1018,1019,1020,1021,1022,1023,1024,1025,1026,1027,1028,1029,1030,1031,1032,1033,1034,1035,1036,1037,1038,1039,1040,1041,1042,1043,1044,1045,1046,1047,1048,1049,1050,1051,1052,1053,1054,1055,1056,1057,1058,1059,1060,1061,1062,1063,1064,1065,1066,1067,1068,1069,1070,1071,1072,1073,1074,1075,1076,1077,1078,1079],{"trials":1207,"activeCount":67},[],{"trials":1209,"activeCount":67},[],{"intervention":991,"totalTrials":63,"cells":1211},{"EARLY_PHASE1":1212,"PHASE1":1214,"PHASE2":1216,"PHASE3":1218,"PHASE4":1224,"NA":1226},{"trials":1213,"activeCount":67},[],{"trials":1215,"activeCount":67},[],{"trials":1217,"activeCount":67},[],{"trials":1219,"activeCount":67},[1220],{"nctId":972,"briefTitle":973,"status":166,"phases":1221,"primaryCompletion":975,"completion":975,"start":976,"enrollment":977,"conditions":1222,"interventions":1223},[58],[979,980,954,981,982],[961,984,985,986,987,988,989,990,991,992,993,994,995,996,997,998,999,1000,1001,1002,1003,1004,1005,1006,1007,1008,1009,1010,1011,1012,1013,1014,1015,1016,1017,1018,1019,1020,1021,1022,1023,1024,1025,1026,1027,1028,1029,1030,1031,1032,1033,1034,1035,1036,1037,1038,1039,1040,1041,1042,1043,1044,1045,1046,1047,1048,1049,1050,1051,1052,1053,1054,1055,1056,1057,1058,1059,1060,1061,1062,1063,1064,1065,1066,1067,1068,1069,1070,1071,1072,1073,1074,1075,1076,1077,1078,1079],{"trials":1225,"activeCount":67},[],{"trials":1227,"activeCount":67},[],{"intervention":992,"totalTrials":63,"cells":1229},{"EARLY_PHASE1":1230,"PHASE1":1232,"PHASE2":1234,"PHASE3":1236,"PHASE4":1242,"NA":1244},{"trials":1231,"activeCount":67},[],{"trials":1233,"activeCount":67},[],{"trials":1235,"activeCount":67},[],{"trials":1237,"activeCount":67},[1238],{"nctId":972,"briefTitle":973,"status":166,"phases":1239,"primaryCompletion":975,"completion":975,"start":976,"enrollment":977,"conditions":1240,"interventions":1241},[58],[979,980,954,981,982],[961,984,985,986,987,988,989,990,991,992,993,994,995,996,997,998,999,1000,1001,1002,1003,1004,1005,1006,1007,1008,1009,1010,1011,1012,1013,1014,1015,1016,1017,1018,1019,1020,1021,1022,1023,1024,1025,1026,1027,1028,1029,1030,1031,1032,1033,1034,1035,1036,1037,1038,1039,1040,1041,1042,1043,1044,1045,1046,1047,1048,1049,1050,1051,1052,1053,1054,1055,1056,1057,1058,1059,1060,1061,1062,1063,1064,1065,1066,1067,1068,1069,1070,1071,1072,1073,1074,1075,1076,1077,1078,1079],{"trials":1243,"activeCount":67},[],{"trials":1245,"activeCount":67},[],{"intervention":993,"totalTrials":63,"cells":1247},{"EARLY_PHASE1":1248,"PHASE1":1250,"PHASE2":1252,"PHASE3":1254,"PHASE4":1260,"NA":1262},{"trials":1249,"activeCount":67},[],{"trials":1251,"activeCount":67},[],{"trials":1253,"activeCount":67},[],{"trials":1255,"activeCount":67},[1256],{"nctId":972,"briefTitle":973,"status":166,"phases":1257,"primaryCompletion":975,"completion":975,"start":976,"enrollment":977,"conditions":1258,"interventions":1259},[58],[979,980,954,981,982],[961,984,985,986,987,988,989,990,991,992,993,994,995,996,997,998,999,1000,1001,1002,1003,1004,1005,1006,1007,1008,1009,1010,1011,1012,1013,1014,1015,1016,1017,1018,1019,1020,1021,1022,1023,1024,1025,1026,1027,1028,1029,1030,1031,1032,1033,1034,1035,1036,1037,1038,1039,1040,1041,1042,1043,1044,1045,1046,1047,1048,1049,1050,1051,1052,1053,1054,1055,1056,1057,1058,1059,1060,1061,1062,1063,1064,1065,1066,1067,1068,1069,1070,1071,1072,1073,1074,1075,1076,1077,1078,1079],{"trials":1261,"activeCount":67},[],{"trials":1263,"activeCount":67},[],{"intervention":994,"totalTrials":63,"cells":1265},{"EARLY_PHASE1":1266,"PHASE1":1268,"PHASE2":1270,"PHASE3":1272,"PHASE4":1278,"NA":1280},{"trials":1267,"activeCount":67},[],{"trials":1269,"activeCount":67},[],{"trials":1271,"activeCount":67},[],{"trials":1273,"activeCount":67},[1274],{"nctId":972,"briefTitle":973,"status":166,"phases":1275,"primaryCompletion":975,"completion":975,"start":976,"enrollment":977,"conditions":1276,"interventions":1277},[58],[979,980,954,981,982],[961,984,985,986,987,988,989,990,991,992,993,994,995,996,997,998,999,1000,1001,1002,1003,1004,1005,1006,1007,1008,1009,1010,1011,1012,1013,1014,1015,1016,1017,1018,1019,1020,1021,1022,1023,1024,1025,1026,1027,1028,1029,1030,1031,1032,1033,1034,1035,1036,1037,1038,1039,1040,1041,1042,1043,1044,1045,1046,1047,1048,1049,1050,1051,1052,1053,1054,1055,1056,1057,1058,1059,1060,1061,1062,1063,1064,1065,1066,1067,1068,1069,1070,1071,1072,1073,1074,1075,1076,1077,1078,1079],{"trials":1279,"activeCount":67},[],{"trials":1281,"activeCount":67},[],{"intervention":995,"totalTrials":63,"cells":1283},{"EARLY_PHASE1":1284,"PHASE1":1286,"PHASE2":1288,"PHASE3":1290,"PHASE4":1296,"NA":1298},{"trials":1285,"activeCount":67},[],{"trials":1287,"activeCount":67},[],{"trials":1289,"activeCount":67},[],{"trials":1291,"activeCount":67},[1292],{"nctId":972,"briefTitle":973,"status":166,"phases":1293,"primaryCompletion":975,"completion":975,"start":976,"enrollment":977,"conditions":1294,"interventions":1295},[58],[979,980,954,981,982],[961,984,985,986,987,988,989,990,991,992,993,994,995,996,997,998,999,1000,1001,1002,1003,1004,1005,1006,1007,1008,1009,1010,1011,1012,1013,1014,1015,1016,1017,1018,1019,1020,1021,1022,1023,1024,1025,1026,1027,1028,1029,1030,1031,1032,1033,1034,1035,1036,1037,1038,1039,1040,1041,1042,1043,1044,1045,1046,1047,1048,1049,1050,1051,1052,1053,1054,1055,1056,1057,1058,1059,1060,1061,1062,1063,1064,1065,1066,1067,1068,1069,1070,1071,1072,1073,1074,1075,1076,1077,1078,1079],{"trials":1297,"activeCount":67},[],{"trials":1299,"activeCount":67},[],{"intervention":996,"totalTrials":63,"cells":1301},{"EARLY_PHASE1":1302,"PHASE1":1304,"PHASE2":1306,"PHASE3":1308,"PHASE4":1314,"NA":1316},{"trials":1303,"activeCount":67},[],{"trials":1305,"activeCount":67},[],{"trials":1307,"activeCount":67},[],{"trials":1309,"activeCount":67},[1310],{"nctId":972,"briefTitle":973,"status":166,"phases":1311,"primaryCompletion":975,"completion":975,"start":976,"enrollment":977,"conditions":1312,"interventions":1313},[58],[979,980,954,981,982],[961,984,985,986,987,988,989,990,991,992,993,994,995,996,997,998,999,1000,1001,1002,1003,1004,1005,1006,1007,1008,1009,1010,1011,1012,1013,1014,1015,1016,1017,1018,1019,1020,1021,1022,1023,1024,1025,1026,1027,1028,1029,1030,1031,1032,1033,1034,1035,1036,1037,1038,1039,1040,1041,1042,1043,1044,1045,1046,1047,1048,1049,1050,1051,1052,1053,1054,1055,1056,1057,1058,1059,1060,1061,1062,1063,1064,1065,1066,1067,1068,1069,1070,1071,1072,1073,1074,1075,1076,1077,1078,1079],{"trials":1315,"activeCount":67},[],{"trials":1317,"activeCount":67},[],{"intervention":997,"totalTrials":63,"cells":1319},{"EARLY_PHASE1":1320,"PHASE1":1322,"PHASE2":1324,"PHASE3":1326,"PHASE4":1332,"NA":1334},{"trials":1321,"activeCount":67},[],{"trials":1323,"activeCount":67},[],{"trials":1325,"activeCount":67},[],{"trials":1327,"activeCount":67},[1328],{"nctId":972,"briefTitle":973,"status":166,"phases":1329,"primaryCompletion":975,"completion":975,"start":976,"enrollment":977,"conditions":1330,"interventions":1331},[58],[979,980,954,981,982],[961,984,985,986,987,988,989,990,991,992,993,994,995,996,997,998,999,1000,1001,1002,1003,1004,1005,1006,1007,1008,1009,1010,1011,1012,1013,1014,1015,1016,1017,1018,1019,1020,1021,1022,1023,1024,1025,1026,1027,1028,1029,1030,1031,1032,1033,1034,1035,1036,1037,1038,1039,1040,1041,1042,1043,1044,1045,1046,1047,1048,1049,1050,1051,1052,1053,1054,1055,1056,1057,1058,1059,1060,1061,1062,1063,1064,1065,1066,1067,1068,1069,1070,1071,1072,1073,1074,1075,1076,1077,1078,1079],{"trials":1333,"activeCount":67},[],{"trials":1335,"activeCount":67},[],{"intervention":998,"totalTrials":63,"cells":1337},{"EARLY_PHASE1":1338,"PHASE1":1340,"PHASE2":1342,"PHASE3":1344,"PHASE4":1350,"NA":1352},{"trials":1339,"activeCount":67},[],{"trials":1341,"activeCount":67},[],{"trials":1343,"activeCount":67},[],{"trials":1345,"activeCount":67},[1346],{"nctId":972,"briefTitle":973,"status":166,"phases":1347,"primaryCompletion":975,"completion":975,"start":976,"enrollment":977,"conditions":1348,"interventions":1349},[58],[979,980,954,981,982],[961,984,985,986,987,988,989,990,991,992,993,994,995,996,997,998,999,1000,1001,1002,1003,1004,1005,1006,1007,1008,1009,1010,1011,1012,1013,1014,1015,1016,1017,1018,1019,1020,1021,1022,1023,1024,1025,1026,1027,1028,1029,1030,1031,1032,1033,1034,1035,1036,1037,1038,1039,1040,1041,1042,1043,1044,1045,1046,1047,1048,1049,1050,1051,1052,1053,1054,1055,1056,1057,1058,1059,1060,1061,1062,1063,1064,1065,1066,1067,1068,1069,1070,1071,1072,1073,1074,1075,1076,1077,1078,1079],{"trials":1351,"activeCount":67},[],{"trials":1353,"activeCount":67},[],{"intervention":999,"totalTrials":63,"cells":1355},{"EARLY_PHASE1":1356,"PHASE1":1358,"PHASE2":1360,"PHASE3":1362,"PHASE4":1368,"NA":1370},{"trials":1357,"activeCount":67},[],{"trials":1359,"activeCount":67},[],{"trials":1361,"activeCount":67},[],{"trials":1363,"activeCount":67},[1364],{"nctId":972,"briefTitle":973,"status":166,"phases":1365,"primaryCompletion":975,"completion":975,"start":976,"enrollment":977,"conditions":1366,"interventions":1367},[58],[979,980,954,981,982],[961,984,985,986,987,988,989,990,991,992,993,994,995,996,997,998,999,1000,1001,1002,1003,1004,1005,1006,1007,1008,1009,1010,1011,1012,1013,1014,1015,1016,1017,1018,1019,1020,1021,1022,1023,1024,1025,1026,1027,1028,1029,1030,1031,1032,1033,1034,1035,1036,1037,1038,1039,1040,1041,1042,1043,1044,1045,1046,1047,1048,1049,1050,1051,1052,1053,1054,1055,1056,1057,1058,1059,1060,1061,1062,1063,1064,1065,1066,1067,1068,1069,1070,1071,1072,1073,1074,1075,1076,1077,1078,1079],{"trials":1369,"activeCount":67},[],{"trials":1371,"activeCount":67},[],{"intervention":1000,"totalTrials":63,"cells":1373},{"EARLY_PHASE1":1374,"PHASE1":1376,"PHASE2":1378,"PHASE3":1380,"PHASE4":1386,"NA":1388},{"trials":1375,"activeCount":67},[],{"trials":1377,"activeCount":67},[],{"trials":1379,"activeCount":67},[],{"trials":1381,"activeCount":67},[1382],{"nctId":972,"briefTitle":973,"status":166,"phases":1383,"primaryCompletion":975,"completion":975,"start":976,"enrollment":977,"conditions":1384,"interventions":1385},[58],[979,980,954,981,982],[961,984,985,986,987,988,989,990,991,992,993,994,995,996,997,998,999,1000,1001,1002,1003,1004,1005,1006,1007,1008,1009,1010,1011,1012,1013,1014,1015,1016,1017,1018,1019,1020,1021,1022,1023,1024,1025,1026,1027,1028,1029,1030,1031,1032,1033,1034,1035,1036,1037,1038,1039,1040,1041,1042,1043,1044,1045,1046,1047,1048,1049,1050,1051,1052,1053,1054,1055,1056,1057,1058,1059,1060,1061,1062,1063,1064,1065,1066,1067,1068,1069,1070,1071,1072,1073,1074,1075,1076,1077,1078,1079],{"trials":1387,"activeCount":67},[],{"trials":1389,"activeCount":67},[],{"intervention":1001,"totalTrials":63,"cells":1391},{"EARLY_PHASE1":1392,"PHASE1":1394,"PHASE2":1396,"PHASE3":1398,"PHASE4":1404,"NA":1406},{"trials":1393,"activeCount":67},[],{"trials":1395,"activeCount":67},[],{"trials":1397,"activeCount":67},[],{"trials":1399,"activeCount":67},[1400],{"nctId":972,"briefTitle":973,"status":166,"phases":1401,"primaryCompletion":975,"completion":975,"start":976,"enrollment":977,"conditions":1402,"interventions":1403},[58],[979,980,954,981,982],[961,984,985,986,987,988,989,990,991,992,993,994,995,996,997,998,999,1000,1001,1002,1003,1004,1005,1006,1007,1008,1009,1010,1011,1012,1013,1014,1015,1016,1017,1018,1019,1020,1021,1022,1023,1024,1025,1026,1027,1028,1029,1030,1031,1032,1033,1034,1035,1036,1037,1038,1039,1040,1041,1042,1043,1044,1045,1046,1047,1048,1049,1050,1051,1052,1053,1054,1055,1056,1057,1058,1059,1060,1061,1062,1063,1064,1065,1066,1067,1068,1069,1070,1071,1072,1073,1074,1075,1076,1077,1078,1079],{"trials":1405,"activeCount":67},[],{"trials":1407,"activeCount":67},[],{"intervention":1002,"totalTrials":63,"cells":1409},{"EARLY_PHASE1":1410,"PHASE1":1412,"PHASE2":1414,"PHASE3":1416,"PHASE4":1422,"NA":1424},{"trials":1411,"activeCount":67},[],{"trials":1413,"activeCount":67},[],{"trials":1415,"activeCount":67},[],{"trials":1417,"activeCount":67},[1418],{"nctId":972,"briefTitle":973,"status":166,"phases":1419,"primaryCompletion":975,"completion":975,"start":976,"enrollment":977,"conditions":1420,"interventions":1421},[58],[979,980,954,981,982],[961,984,985,986,987,988,989,990,991,992,993,994,995,996,997,998,999,1000,1001,1002,1003,1004,1005,1006,1007,1008,1009,1010,1011,1012,1013,1014,1015,1016,1017,1018,1019,1020,1021,1022,1023,1024,1025,1026,1027,1028,1029,1030,1031,1032,1033,1034,1035,1036,1037,1038,1039,1040,1041,1042,1043,1044,1045,1046,1047,1048,1049,1050,1051,1052,1053,1054,1055,1056,1057,1058,1059,1060,1061,1062,1063,1064,1065,1066,1067,1068,1069,1070,1071,1072,1073,1074,1075,1076,1077,1078,1079],{"trials":1423,"activeCount":67},[],{"trials":1425,"activeCount":67},[],{"intervention":1003,"totalTrials":63,"cells":1427},{"EARLY_PHASE1":1428,"PHASE1":1430,"PHASE2":1432,"PHASE3":1434,"PHASE4":1440,"NA":1442},{"trials":1429,"activeCount":67},[],{"trials":1431,"activeCount":67},[],{"trials":1433,"activeCount":67},[],{"trials":1435,"activeCount":67},[1436],{"nctId":972,"briefTitle":973,"status":166,"phases":1437,"primaryCompletion":975,"completion":975,"start":976,"enrollment":977,"conditions":1438,"interventions":1439},[58],[979,980,954,981,982],[961,984,985,986,987,988,989,990,991,992,993,994,995,996,997,998,999,1000,1001,1002,1003,1004,1005,1006,1007,1008,1009,1010,1011,1012,1013,1014,1015,1016,1017,1018,1019,1020,1021,1022,1023,1024,1025,1026,1027,1028,1029,1030,1031,1032,1033,1034,1035,1036,1037,1038,1039,1040,1041,1042,1043,1044,1045,1046,1047,1048,1049,1050,1051,1052,1053,1054,1055,1056,1057,1058,1059,1060,1061,1062,1063,1064,1065,1066,1067,1068,1069,1070,1071,1072,1073,1074,1075,1076,1077,1078,1079],{"trials":1441,"activeCount":67},[],{"trials":1443,"activeCount":67},[],{"intervention":1004,"totalTrials":63,"cells":1445},{"EARLY_PHASE1":1446,"PHASE1":1448,"PHASE2":1450,"PHASE3":1452,"PHASE4":1458,"NA":1460},{"trials":1447,"activeCount":67},[],{"trials":1449,"activeCount":67},[],{"trials":1451,"activeCount":67},[],{"trials":1453,"activeCount":67},[1454],{"nctId":972,"briefTitle":973,"status":166,"phases":1455,"primaryCompletion":975,"completion":975,"start":976,"enrollment":977,"conditions":1456,"interventions":1457},[58],[979,980,954,981,982],[961,984,985,986,987,988,989,990,991,992,993,994,995,996,997,998,999,1000,1001,1002,1003,1004,1005,1006,1007,1008,1009,1010,1011,1012,1013,1014,1015,1016,1017,1018,1019,1020,1021,1022,1023,1024,1025,1026,1027,1028,1029,1030,1031,1032,1033,1034,1035,1036,1037,1038,1039,1040,1041,1042,1043,1044,1045,1046,1047,1048,1049,1050,1051,1052,1053,1054,1055,1056,1057,1058,1059,1060,1061,1062,1063,1064,1065,1066,1067,1068,1069,1070,1071,1072,1073,1074,1075,1076,1077,1078,1079],{"trials":1459,"activeCount":67},[],{"trials":1461,"activeCount":67},[],{"intervention":1005,"totalTrials":63,"cells":1463},{"EARLY_PHASE1":1464,"PHASE1":1466,"PHASE2":1468,"PHASE3":1470,"PHASE4":1476,"NA":1478},{"trials":1465,"activeCount":67},[],{"trials":1467,"activeCount":67},[],{"trials":1469,"activeCount":67},[],{"trials":1471,"activeCount":67},[1472],{"nctId":972,"briefTitle":973,"status":166,"phases":1473,"primaryCompletion":975,"completion":975,"start":976,"enrollment":977,"conditions":1474,"interventions":1475},[58],[979,980,954,981,982],[961,984,985,986,987,988,989,990,991,992,993,994,995,996,997,998,999,1000,1001,1002,1003,1004,1005,1006,1007,1008,1009,1010,1011,1012,1013,1014,1015,1016,1017,1018,1019,1020,1021,1022,1023,1024,1025,1026,1027,1028,1029,1030,1031,1032,1033,1034,1035,1036,1037,1038,1039,1040,1041,1042,1043,1044,1045,1046,1047,1048,1049,1050,1051,1052,1053,1054,1055,1056,1057,1058,1059,1060,1061,1062,1063,1064,1065,1066,1067,1068,1069,1070,1071,1072,1073,1074,1075,1076,1077,1078,1079],{"trials":1477,"activeCount":67},[],{"trials":1479,"activeCount":67},[],{"intervention":1006,"totalTrials":63,"cells":1481},{"EARLY_PHASE1":1482,"PHASE1":1484,"PHASE2":1486,"PHASE3":1488,"PHASE4":1494,"NA":1496},{"trials":1483,"activeCount":67},[],{"trials":1485,"activeCount":67},[],{"trials":1487,"activeCount":67},[],{"trials":1489,"activeCount":67},[1490],{"nctId":972,"briefTitle":973,"status":166,"phases":1491,"primaryCompletion":975,"completion":975,"start":976,"enrollment":977,"conditions":1492,"interventions":1493},[58],[979,980,954,981,982],[961,984,985,986,987,988,989,990,991,992,993,994,995,996,997,998,999,1000,1001,1002,1003,1004,1005,1006,1007,1008,1009,1010,1011,1012,1013,1014,1015,1016,1017,1018,1019,1020,1021,1022,1023,1024,1025,1026,1027,1028,1029,1030,1031,1032,1033,1034,1035,1036,1037,1038,1039,1040,1041,1042,1043,1044,1045,1046,1047,1048,1049,1050,1051,1052,1053,1054,1055,1056,1057,1058,1059,1060,1061,1062,1063,1064,1065,1066,1067,1068,1069,1070,1071,1072,1073,1074,1075,1076,1077,1078,1079],{"trials":1495,"activeCount":67},[],{"trials":1497,"activeCount":67},[],{"intervention":1007,"totalTrials":63,"cells":1499},{"EARLY_PHASE1":1500,"PHASE1":1502,"PHASE2":1504,"PHASE3":1506,"PHASE4":1512,"NA":1514},{"trials":1501,"activeCount":67},[],{"trials":1503,"activeCount":67},[],{"trials":1505,"activeCount":67},[],{"trials":1507,"activeCount":67},[1508],{"nctId":972,"briefTitle":973,"status":166,"phases":1509,"primaryCompletion":975,"completion":975,"start":976,"enrollment":977,"conditions":1510,"interventions":1511},[58],[979,980,954,981,982],[961,984,985,986,987,988,989,990,991,992,993,994,995,996,997,998,999,1000,1001,1002,1003,1004,1005,1006,1007,1008,1009,1010,1011,1012,1013,1014,1015,1016,1017,1018,1019,1020,1021,1022,1023,1024,1025,1026,1027,1028,1029,1030,1031,1032,1033,1034,1035,1036,1037,1038,1039,1040,1041,1042,1043,1044,1045,1046,1047,1048,1049,1050,1051,1052,1053,1054,1055,1056,1057,1058,1059,1060,1061,1062,1063,1064,1065,1066,1067,1068,1069,1070,1071,1072,1073,1074,1075,1076,1077,1078,1079],{"trials":1513,"activeCount":67},[],{"trials":1515,"activeCount":67},[],{"intervention":1008,"totalTrials":63,"cells":1517},{"EARLY_PHASE1":1518,"PHASE1":1520,"PHASE2":1522,"PHASE3":1524,"PHASE4":1530,"NA":1532},{"trials":1519,"activeCount":67},[],{"trials":1521,"activeCount":67},[],{"trials":1523,"activeCount":67},[],{"trials":1525,"activeCount":67},[1526],{"nctId":972,"briefTitle":973,"status":166,"phases":1527,"primaryCompletion":975,"completion":975,"start":976,"enrollment":977,"conditions":1528,"interventions":1529},[58],[979,980,954,981,982],[961,984,985,986,987,988,989,990,991,992,993,994,995,996,997,998,999,1000,1001,1002,1003,1004,1005,1006,1007,1008,1009,1010,1011,1012,1013,1014,1015,1016,1017,1018,1019,1020,1021,1022,1023,1024,1025,1026,1027,1028,1029,1030,1031,1032,1033,1034,1035,1036,1037,1038,1039,1040,1041,1042,1043,1044,1045,1046,1047,1048,1049,1050,1051,1052,1053,1054,1055,1056,1057,1058,1059,1060,1061,1062,1063,1064,1065,1066,1067,1068,1069,1070,1071,1072,1073,1074,1075,1076,1077,1078,1079],{"trials":1531,"activeCount":67},[],{"trials":1533,"activeCount":67},[],{"intervention":1009,"totalTrials":63,"cells":1535},{"EARLY_PHASE1":1536,"PHASE1":1538,"PHASE2":1540,"PHASE3":1542,"PHASE4":1548,"NA":1550},{"trials":1537,"activeCount":67},[],{"trials":1539,"activeCount":67},[],{"trials":1541,"activeCount":67},[],{"trials":1543,"activeCount":67},[1544],{"nctId":972,"briefTitle":973,"status":166,"phases":1545,"primaryCompletion":975,"completion":975,"start":976,"enrollment":977,"conditions":1546,"interventions":1547},[58],[979,980,954,981,982],[961,984,985,986,987,988,989,990,991,992,993,994,995,996,997,998,999,1000,1001,1002,1003,1004,1005,1006,1007,1008,1009,1010,1011,1012,1013,1014,1015,1016,1017,1018,1019,1020,1021,1022,1023,1024,1025,1026,1027,1028,1029,1030,1031,1032,1033,1034,1035,1036,1037,1038,1039,1040,1041,1042,1043,1044,1045,1046,1047,1048,1049,1050,1051,1052,1053,1054,1055,1056,1057,1058,1059,1060,1061,1062,1063,1064,1065,1066,1067,1068,1069,1070,1071,1072,1073,1074,1075,1076,1077,1078,1079],{"trials":1549,"activeCount":67},[],{"trials":1551,"activeCount":67},[],{"intervention":1010,"totalTrials":63,"cells":1553},{"EARLY_PHASE1":1554,"PHASE1":1556,"PHASE2":1558,"PHASE3":1560,"PHASE4":1566,"NA":1568},{"trials":1555,"activeCount":67},[],{"trials":1557,"activeCount":67},[],{"trials":1559,"activeCount":67},[],{"trials":1561,"activeCount":67},[1562],{"nctId":972,"briefTitle":973,"status":166,"phases":1563,"primaryCompletion":975,"completion":975,"start":976,"enrollment":977,"conditions":1564,"interventions":1565},[58],[979,980,954,981,982],[961,984,985,986,987,988,989,990,991,992,993,994,995,996,997,998,999,1000,1001,1002,1003,1004,1005,1006,1007,1008,1009,1010,1011,1012,1013,1014,1015,1016,1017,1018,1019,1020,1021,1022,1023,1024,1025,1026,1027,1028,1029,1030,1031,1032,1033,1034,1035,1036,1037,1038,1039,1040,1041,1042,1043,1044,1045,1046,1047,1048,1049,1050,1051,1052,1053,1054,1055,1056,1057,1058,1059,1060,1061,1062,1063,1064,1065,1066,1067,1068,1069,1070,1071,1072,1073,1074,1075,1076,1077,1078,1079],{"trials":1567,"activeCount":67},[],{"trials":1569,"activeCount":67},[],{"intervention":1011,"totalTrials":63,"cells":1571},{"EARLY_PHASE1":1572,"PHASE1":1574,"PHASE2":1576,"PHASE3":1578,"PHASE4":1584,"NA":1586},{"trials":1573,"activeCount":67},[],{"trials":1575,"activeCount":67},[],{"trials":1577,"activeCount":67},[],{"trials":1579,"activeCount":67},[1580],{"nctId":972,"briefTitle":973,"status":166,"phases":1581,"primaryCompletion":975,"completion":975,"start":976,"enrollment":977,"conditions":1582,"interventions":1583},[58],[979,980,954,981,982],[961,984,985,986,987,988,989,990,991,992,993,994,995,996,997,998,999,1000,1001,1002,1003,1004,1005,1006,1007,1008,1009,1010,1011,1012,1013,1014,1015,1016,1017,1018,1019,1020,1021,1022,1023,1024,1025,1026,1027,1028,1029,1030,1031,1032,1033,1034,1035,1036,1037,1038,1039,1040,1041,1042,1043,1044,1045,1046,1047,1048,1049,1050,1051,1052,1053,1054,1055,1056,1057,1058,1059,1060,1061,1062,1063,1064,1065,1066,1067,1068,1069,1070,1071,1072,1073,1074,1075,1076,1077,1078,1079],{"trials":1585,"activeCount":67},[],{"trials":1587,"activeCount":67},[],{"intervention":1012,"totalTrials":63,"cells":1589},{"EARLY_PHASE1":1590,"PHASE1":1592,"PHASE2":1594,"PHASE3":1596,"PHASE4":1602,"NA":1604},{"trials":1591,"activeCount":67},[],{"trials":1593,"activeCount":67},[],{"trials":1595,"activeCount":67},[],{"trials":1597,"activeCount":67},[1598],{"nctId":972,"briefTitle":973,"status":166,"phases":1599,"primaryCompletion":975,"completion":975,"start":976,"enrollment":977,"conditions":1600,"interventions":1601},[58],[979,980,954,981,982],[961,984,985,986,987,988,989,990,991,992,993,994,995,996,997,998,999,1000,1001,1002,1003,1004,1005,1006,1007,1008,1009,1010,1011,1012,1013,1014,1015,1016,1017,1018,1019,1020,1021,1022,1023,1024,1025,1026,1027,1028,1029,1030,1031,1032,1033,1034,1035,1036,1037,1038,1039,1040,1041,1042,1043,1044,1045,1046,1047,1048,1049,1050,1051,1052,1053,1054,1055,1056,1057,1058,1059,1060,1061,1062,1063,1064,1065,1066,1067,1068,1069,1070,1071,1072,1073,1074,1075,1076,1077,1078,1079],{"trials":1603,"activeCount":67},[],{"trials":1605,"activeCount":67},[],{"intervention":1013,"totalTrials":63,"cells":1607},{"EARLY_PHASE1":1608,"PHASE1":1610,"PHASE2":1612,"PHASE3":1614,"PHASE4":1620,"NA":1622},{"trials":1609,"activeCount":67},[],{"trials":1611,"activeCount":67},[],{"trials":1613,"activeCount":67},[],{"trials":1615,"activeCount":67},[1616],{"nctId":972,"briefTitle":973,"status":166,"phases":1617,"primaryCompletion":975,"completion":975,"start":976,"enrollment":977,"conditions":1618,"interventions":1619},[58],[979,980,954,981,982],[961,984,985,986,987,988,989,990,991,992,993,994,995,996,997,998,999,1000,1001,1002,1003,1004,1005,1006,1007,1008,1009,1010,1011,1012,1013,1014,1015,1016,1017,1018,1019,1020,1021,1022,1023,1024,1025,1026,1027,1028,1029,1030,1031,1032,1033,1034,1035,1036,1037,1038,1039,1040,1041,1042,1043,1044,1045,1046,1047,1048,1049,1050,1051,1052,1053,1054,1055,1056,1057,1058,1059,1060,1061,1062,1063,1064,1065,1066,1067,1068,1069,1070,1071,1072,1073,1074,1075,1076,1077,1078,1079],{"trials":1621,"activeCount":67},[],{"trials":1623,"activeCount":67},[],{"intervention":1014,"totalTrials":63,"cells":1625},{"EARLY_PHASE1":1626,"PHASE1":1628,"PHASE2":1630,"PHASE3":1632,"PHASE4":1638,"NA":1640},{"trials":1627,"activeCount":67},[],{"trials":1629,"activeCount":67},[],{"trials":1631,"activeCount":67},[],{"trials":1633,"activeCount":67},[1634],{"nctId":972,"briefTitle":973,"status":166,"phases":1635,"primaryCompletion":975,"completion":975,"start":976,"enrollment":977,"conditions":1636,"interventions":1637},[58],[979,980,954,981,982],[961,984,985,986,987,988,989,990,991,992,993,994,995,996,997,998,999,1000,1001,1002,1003,1004,1005,1006,1007,1008,1009,1010,1011,1012,1013,1014,1015,1016,1017,1018,1019,1020,1021,1022,1023,1024,1025,1026,1027,1028,1029,1030,1031,1032,1033,1034,1035,1036,1037,1038,1039,1040,1041,1042,1043,1044,1045,1046,1047,1048,1049,1050,1051,1052,1053,1054,1055,1056,1057,1058,1059,1060,1061,1062,1063,1064,1065,1066,1067,1068,1069,1070,1071,1072,1073,1074,1075,1076,1077,1078,1079],{"trials":1639,"activeCount":67},[],{"trials":1641,"activeCount":67},[],{"intervention":1015,"totalTrials":63,"cells":1643},{"EARLY_PHASE1":1644,"PHASE1":1646,"PHASE2":1648,"PHASE3":1650,"PHASE4":1656,"NA":1658},{"trials":1645,"activeCount":67},[],{"trials":1647,"activeCount":67},[],{"trials":1649,"activeCount":67},[],{"trials":1651,"activeCount":67},[1652],{"nctId":972,"briefTitle":973,"status":166,"phases":1653,"primaryCompletion":975,"completion":975,"start":976,"enrollment":977,"conditions":1654,"interventions":1655},[58],[979,980,954,981,982],[961,984,985,986,987,988,989,990,991,992,993,994,995,996,997,998,999,1000,1001,1002,1003,1004,1005,1006,1007,1008,1009,1010,1011,1012,1013,1014,1015,1016,1017,1018,1019,1020,1021,1022,1023,1024,1025,1026,1027,1028,1029,1030,1031,1032,1033,1034,1035,1036,1037,1038,1039,1040,1041,1042,1043,1044,1045,1046,1047,1048,1049,1050,1051,1052,1053,1054,1055,1056,1057,1058,1059,1060,1061,1062,1063,1064,1065,1066,1067,1068,1069,1070,1071,1072,1073,1074,1075,1076,1077,1078,1079],{"trials":1657,"activeCount":67},[],{"trials":1659,"activeCount":67},[],{"intervention":1016,"totalTrials":63,"cells":1661},{"EARLY_PHASE1":1662,"PHASE1":1664,"PHASE2":1666,"PHASE3":1668,"PHASE4":1674,"NA":1676},{"trials":1663,"activeCount":67},[],{"trials":1665,"activeCount":67},[],{"trials":1667,"activeCount":67},[],{"trials":1669,"activeCount":67},[1670],{"nctId":972,"briefTitle":973,"status":166,"phases":1671,"primaryCompletion":975,"completion":975,"start":976,"enrollment":977,"conditions":1672,"interventions":1673},[58],[979,980,954,981,982],[961,984,985,986,987,988,989,990,991,992,993,994,995,996,997,998,999,1000,1001,1002,1003,1004,1005,1006,1007,1008,1009,1010,1011,1012,1013,1014,1015,1016,1017,1018,1019,1020,1021,1022,1023,1024,1025,1026,1027,1028,1029,1030,1031,1032,1033,1034,1035,1036,1037,1038,1039,1040,1041,1042,1043,1044,1045,1046,1047,1048,1049,1050,1051,1052,1053,1054,1055,1056,1057,1058,1059,1060,1061,1062,1063,1064,1065,1066,1067,1068,1069,1070,1071,1072,1073,1074,1075,1076,1077,1078,1079],{"trials":1675,"activeCount":67},[],{"trials":1677,"activeCount":67},[],{"intervention":1017,"totalTrials":63,"cells":1679},{"EARLY_PHASE1":1680,"PHASE1":1682,"PHASE2":1684,"PHASE3":1686,"PHASE4":1692,"NA":1694},{"trials":1681,"activeCount":67},[],{"trials":1683,"activeCount":67},[],{"trials":1685,"activeCount":67},[],{"trials":1687,"activeCount":67},[1688],{"nctId":972,"briefTitle":973,"status":166,"phases":1689,"primaryCompletion":975,"completion":975,"start":976,"enrollment":977,"conditions":1690,"interventions":1691},[58],[979,980,954,981,982],[961,984,985,986,987,988,989,990,991,992,993,994,995,996,997,998,999,1000,1001,1002,1003,1004,1005,1006,1007,1008,1009,1010,1011,1012,1013,1014,1015,1016,1017,1018,1019,1020,1021,1022,1023,1024,1025,1026,1027,1028,1029,1030,1031,1032,1033,1034,1035,1036,1037,1038,1039,1040,1041,1042,1043,1044,1045,1046,1047,1048,1049,1050,1051,1052,1053,1054,1055,1056,1057,1058,1059,1060,1061,1062,1063,1064,1065,1066,1067,1068,1069,1070,1071,1072,1073,1074,1075,1076,1077,1078,1079],{"trials":1693,"activeCount":67},[],{"trials":1695,"activeCount":67},[],{"intervention":1018,"totalTrials":63,"cells":1697},{"EARLY_PHASE1":1698,"PHASE1":1700,"PHASE2":1702,"PHASE3":1704,"PHASE4":1710,"NA":1712},{"trials":1699,"activeCount":67},[],{"trials":1701,"activeCount":67},[],{"trials":1703,"activeCount":67},[],{"trials":1705,"activeCount":67},[1706],{"nctId":972,"briefTitle":973,"status":166,"phases":1707,"primaryCompletion":975,"completion":975,"start":976,"enrollment":977,"conditions":1708,"interventions":1709},[58],[979,980,954,981,982],[961,984,985,986,987,988,989,990,991,992,993,994,995,996,997,998,999,1000,1001,1002,1003,1004,1005,1006,1007,1008,1009,1010,1011,1012,1013,1014,1015,1016,1017,1018,1019,1020,1021,1022,1023,1024,1025,1026,1027,1028,1029,1030,1031,1032,1033,1034,1035,1036,1037,1038,1039,1040,1041,1042,1043,1044,1045,1046,1047,1048,1049,1050,1051,1052,1053,1054,1055,1056,1057,1058,1059,1060,1061,1062,1063,1064,1065,1066,1067,1068,1069,1070,1071,1072,1073,1074,1075,1076,1077,1078,1079],{"trials":1711,"activeCount":67},[],{"trials":1713,"activeCount":67},[],{"intervention":1019,"totalTrials":63,"cells":1715},{"EARLY_PHASE1":1716,"PHASE1":1718,"PHASE2":1720,"PHASE3":1722,"PHASE4":1728,"NA":1730},{"trials":1717,"activeCount":67},[],{"trials":1719,"activeCount":67},[],{"trials":1721,"activeCount":67},[],{"trials":1723,"activeCount":67},[1724],{"nctId":972,"briefTitle":973,"status":166,"phases":1725,"primaryCompletion":975,"completion":975,"start":976,"enrollment":977,"conditions":1726,"interventions":1727},[58],[979,980,954,981,982],[961,984,985,986,987,988,989,990,991,992,993,994,995,996,997,998,999,1000,1001,1002,1003,1004,1005,1006,1007,1008,1009,1010,1011,1012,1013,1014,1015,1016,1017,1018,1019,1020,1021,1022,1023,1024,1025,1026,1027,1028,1029,1030,1031,1032,1033,1034,1035,1036,1037,1038,1039,1040,1041,1042,1043,1044,1045,1046,1047,1048,1049,1050,1051,1052,1053,1054,1055,1056,1057,1058,1059,1060,1061,1062,1063,1064,1065,1066,1067,1068,1069,1070,1071,1072,1073,1074,1075,1076,1077,1078,1079],{"trials":1729,"activeCount":67},[],{"trials":1731,"activeCount":67},[],{"intervention":1020,"totalTrials":63,"cells":1733},{"EARLY_PHASE1":1734,"PHASE1":1736,"PHASE2":1738,"PHASE3":1740,"PHASE4":1746,"NA":1748},{"trials":1735,"activeCount":67},[],{"trials":1737,"activeCount":67},[],{"trials":1739,"activeCount":67},[],{"trials":1741,"activeCount":67},[1742],{"nctId":972,"briefTitle":973,"status":166,"phases":1743,"primaryCompletion":975,"completion":975,"start":976,"enrollment":977,"conditions":1744,"interventions":1745},[58],[979,980,954,981,982],[961,984,985,986,987,988,989,990,991,992,993,994,995,996,997,998,999,1000,1001,1002,1003,1004,1005,1006,1007,1008,1009,1010,1011,1012,1013,1014,1015,1016,1017,1018,1019,1020,1021,1022,1023,1024,1025,1026,1027,1028,1029,1030,1031,1032,1033,1034,1035,1036,1037,1038,1039,1040,1041,1042,1043,1044,1045,1046,1047,1048,1049,1050,1051,1052,1053,1054,1055,1056,1057,1058,1059,1060,1061,1062,1063,1064,1065,1066,1067,1068,1069,1070,1071,1072,1073,1074,1075,1076,1077,1078,1079],{"trials":1747,"activeCount":67},[],{"trials":1749,"activeCount":67},[],{"intervention":1021,"totalTrials":63,"cells":1751},{"EARLY_PHASE1":1752,"PHASE1":1754,"PHASE2":1756,"PHASE3":1758,"PHASE4":1764,"NA":1766},{"trials":1753,"activeCount":67},[],{"trials":1755,"activeCount":67},[],{"trials":1757,"activeCount":67},[],{"trials":1759,"activeCount":67},[1760],{"nctId":972,"briefTitle":973,"status":166,"phases":1761,"primaryCompletion":975,"completion":975,"start":976,"enrollment":977,"conditions":1762,"interventions":1763},[58],[979,980,954,981,982],[961,984,985,986,987,988,989,990,991,992,993,994,995,996,997,998,999,1000,1001,1002,1003,1004,1005,1006,1007,1008,1009,1010,1011,1012,1013,1014,1015,1016,1017,1018,1019,1020,1021,1022,1023,1024,1025,1026,1027,1028,1029,1030,1031,1032,1033,1034,1035,1036,1037,1038,1039,1040,1041,1042,1043,1044,1045,1046,1047,1048,1049,1050,1051,1052,1053,1054,1055,1056,1057,1058,1059,1060,1061,1062,1063,1064,1065,1066,1067,1068,1069,1070,1071,1072,1073,1074,1075,1076,1077,1078,1079],{"trials":1765,"activeCount":67},[],{"trials":1767,"activeCount":67},[],{"intervention":1022,"totalTrials":63,"cells":1769},{"EARLY_PHASE1":1770,"PHASE1":1772,"PHASE2":1774,"PHASE3":1776,"PHASE4":1782,"NA":1784},{"trials":1771,"activeCount":67},[],{"trials":1773,"activeCount":67},[],{"trials":1775,"activeCount":67},[],{"trials":1777,"activeCount":67},[1778],{"nctId":972,"briefTitle":973,"status":166,"phases":1779,"primaryCompletion":975,"completion":975,"start":976,"enrollment":977,"conditions":1780,"interventions":1781},[58],[979,980,954,981,982],[961,984,985,986,987,988,989,990,991,992,993,994,995,996,997,998,999,1000,1001,1002,1003,1004,1005,1006,1007,1008,1009,1010,1011,1012,1013,1014,1015,1016,1017,1018,1019,1020,1021,1022,1023,1024,1025,1026,1027,1028,1029,1030,1031,1032,1033,1034,1035,1036,1037,1038,1039,1040,1041,1042,1043,1044,1045,1046,1047,1048,1049,1050,1051,1052,1053,1054,1055,1056,1057,1058,1059,1060,1061,1062,1063,1064,1065,1066,1067,1068,1069,1070,1071,1072,1073,1074,1075,1076,1077,1078,1079],{"trials":1783,"activeCount":67},[],{"trials":1785,"activeCount":67},[],{"intervention":1023,"totalTrials":63,"cells":1787},{"EARLY_PHASE1":1788,"PHASE1":1790,"PHASE2":1792,"PHASE3":1794,"PHASE4":1800,"NA":1802},{"trials":1789,"activeCount":67},[],{"trials":1791,"activeCount":67},[],{"trials":1793,"activeCount":67},[],{"trials":1795,"activeCount":67},[1796],{"nctId":972,"briefTitle":973,"status":166,"phases":1797,"primaryCompletion":975,"completion":975,"start":976,"enrollment":977,"conditions":1798,"interventions":1799},[58],[979,980,954,981,982],[961,984,985,986,987,988,989,990,991,992,993,994,995,996,997,998,999,1000,1001,1002,1003,1004,1005,1006,1007,1008,1009,1010,1011,1012,1013,1014,1015,1016,1017,1018,1019,1020,1021,1022,1023,1024,1025,1026,1027,1028,1029,1030,1031,1032,1033,1034,1035,1036,1037,1038,1039,1040,1041,1042,1043,1044,1045,1046,1047,1048,1049,1050,1051,1052,1053,1054,1055,1056,1057,1058,1059,1060,1061,1062,1063,1064,1065,1066,1067,1068,1069,1070,1071,1072,1073,1074,1075,1076,1077,1078,1079],{"trials":1801,"activeCount":67},[],{"trials":1803,"activeCount":67},[],{"intervention":1024,"totalTrials":63,"cells":1805},{"EARLY_PHASE1":1806,"PHASE1":1808,"PHASE2":1810,"PHASE3":1812,"PHASE4":1818,"NA":1820},{"trials":1807,"activeCount":67},[],{"trials":1809,"activeCount":67},[],{"trials":1811,"activeCount":67},[],{"trials":1813,"activeCount":67},[1814],{"nctId":972,"briefTitle":973,"status":166,"phases":1815,"primaryCompletion":975,"completion":975,"start":976,"enrollment":977,"conditions":1816,"interventions":1817},[58],[979,980,954,981,982],[961,984,985,986,987,988,989,990,991,992,993,994,995,996,997,998,999,1000,1001,1002,1003,1004,1005,1006,1007,1008,1009,1010,1011,1012,1013,1014,1015,1016,1017,1018,1019,1020,1021,1022,1023,1024,1025,1026,1027,1028,1029,1030,1031,1032,1033,1034,1035,1036,1037,1038,1039,1040,1041,1042,1043,1044,1045,1046,1047,1048,1049,1050,1051,1052,1053,1054,1055,1056,1057,1058,1059,1060,1061,1062,1063,1064,1065,1066,1067,1068,1069,1070,1071,1072,1073,1074,1075,1076,1077,1078,1079],{"trials":1819,"activeCount":67},[],{"trials":1821,"activeCount":67},[],{"intervention":1025,"totalTrials":63,"cells":1823},{"EARLY_PHASE1":1824,"PHASE1":1826,"PHASE2":1828,"PHASE3":1830,"PHASE4":1836,"NA":1838},{"trials":1825,"activeCount":67},[],{"trials":1827,"activeCount":67},[],{"trials":1829,"activeCount":67},[],{"trials":1831,"activeCount":67},[1832],{"nctId":972,"briefTitle":973,"status":166,"phases":1833,"primaryCompletion":975,"completion":975,"start":976,"enrollment":977,"conditions":1834,"interventions":1835},[58],[979,980,954,981,982],[961,984,985,986,987,988,989,990,991,992,993,994,995,996,997,998,999,1000,1001,1002,1003,1004,1005,1006,1007,1008,1009,1010,1011,1012,1013,1014,1015,1016,1017,1018,1019,1020,1021,1022,1023,1024,1025,1026,1027,1028,1029,1030,1031,1032,1033,1034,1035,1036,1037,1038,1039,1040,1041,1042,1043,1044,1045,1046,1047,1048,1049,1050,1051,1052,1053,1054,1055,1056,1057,1058,1059,1060,1061,1062,1063,1064,1065,1066,1067,1068,1069,1070,1071,1072,1073,1074,1075,1076,1077,1078,1079],{"trials":1837,"activeCount":67},[],{"trials":1839,"activeCount":67},[],{"intervention":1026,"totalTrials":63,"cells":1841},{"EARLY_PHASE1":1842,"PHASE1":1844,"PHASE2":1846,"PHASE3":1848,"PHASE4":1854,"NA":1856},{"trials":1843,"activeCount":67},[],{"trials":1845,"activeCount":67},[],{"trials":1847,"activeCount":67},[],{"trials":1849,"activeCount":67},[1850],{"nctId":972,"briefTitle":973,"status":166,"phases":1851,"primaryCompletion":975,"completion":975,"start":976,"enrollment":977,"conditions":1852,"interventions":1853},[58],[979,980,954,981,982],[961,984,985,986,987,988,989,990,991,992,993,994,995,996,997,998,999,1000,1001,1002,1003,1004,1005,1006,1007,1008,1009,1010,1011,1012,1013,1014,1015,1016,1017,1018,1019,1020,1021,1022,1023,1024,1025,1026,1027,1028,1029,1030,1031,1032,1033,1034,1035,1036,1037,1038,1039,1040,1041,1042,1043,1044,1045,1046,1047,1048,1049,1050,1051,1052,1053,1054,1055,1056,1057,1058,1059,1060,1061,1062,1063,1064,1065,1066,1067,1068,1069,1070,1071,1072,1073,1074,1075,1076,1077,1078,1079],{"trials":1855,"activeCount":67},[],{"trials":1857,"activeCount":67},[],{"intervention":1027,"totalTrials":63,"cells":1859},{"EARLY_PHASE1":1860,"PHASE1":1862,"PHASE2":1864,"PHASE3":1866,"PHASE4":1872,"NA":1874},{"trials":1861,"activeCount":67},[],{"trials":1863,"activeCount":67},[],{"trials":1865,"activeCount":67},[],{"trials":1867,"activeCount":67},[1868],{"nctId":972,"briefTitle":973,"status":166,"phases":1869,"primaryCompletion":975,"completion":975,"start":976,"enrollment":977,"conditions":1870,"interventions":1871},[58],[979,980,954,981,982],[961,984,985,986,987,988,989,990,991,992,993,994,995,996,997,998,999,1000,1001,1002,1003,1004,1005,1006,1007,1008,1009,1010,1011,1012,1013,1014,1015,1016,1017,1018,1019,1020,1021,1022,1023,1024,1025,1026,1027,1028,1029,1030,1031,1032,1033,1034,1035,1036,1037,1038,1039,1040,1041,1042,1043,1044,1045,1046,1047,1048,1049,1050,1051,1052,1053,1054,1055,1056,1057,1058,1059,1060,1061,1062,1063,1064,1065,1066,1067,1068,1069,1070,1071,1072,1073,1074,1075,1076,1077,1078,1079],{"trials":1873,"activeCount":67},[],{"trials":1875,"activeCount":67},[],{"intervention":1028,"totalTrials":63,"cells":1877},{"EARLY_PHASE1":1878,"PHASE1":1880,"PHASE2":1882,"PHASE3":1884,"PHASE4":1890,"NA":1892},{"trials":1879,"activeCount":67},[],{"trials":1881,"activeCount":67},[],{"trials":1883,"activeCount":67},[],{"trials":1885,"activeCount":67},[1886],{"nctId":972,"briefTitle":973,"status":166,"phases":1887,"primaryCompletion":975,"completion":975,"start":976,"enrollment":977,"conditions":1888,"interventions":1889},[58],[979,980,954,981,982],[961,984,985,986,987,988,989,990,991,992,993,994,995,996,997,998,999,1000,1001,1002,1003,1004,1005,1006,1007,1008,1009,1010,1011,1012,1013,1014,1015,1016,1017,1018,1019,1020,1021,1022,1023,1024,1025,1026,1027,1028,1029,1030,1031,1032,1033,1034,1035,1036,1037,1038,1039,1040,1041,1042,1043,1044,1045,1046,1047,1048,1049,1050,1051,1052,1053,1054,1055,1056,1057,1058,1059,1060,1061,1062,1063,1064,1065,1066,1067,1068,1069,1070,1071,1072,1073,1074,1075,1076,1077,1078,1079],{"trials":1891,"activeCount":67},[],{"trials":1893,"activeCount":67},[],{"intervention":1029,"totalTrials":63,"cells":1895},{"EARLY_PHASE1":1896,"PHASE1":1898,"PHASE2":1900,"PHASE3":1902,"PHASE4":1908,"NA":1910},{"trials":1897,"activeCount":67},[],{"trials":1899,"activeCount":67},[],{"trials":1901,"activeCount":67},[],{"trials":1903,"activeCount":67},[1904],{"nctId":972,"briefTitle":973,"status":166,"phases":1905,"primaryCompletion":975,"completion":975,"start":976,"enrollment":977,"conditions":1906,"interventions":1907},[58],[979,980,954,981,982],[961,984,985,986,987,988,989,990,991,992,993,994,995,996,997,998,999,1000,1001,1002,1003,1004,1005,1006,1007,1008,1009,1010,1011,1012,1013,1014,1015,1016,1017,1018,1019,1020,1021,1022,1023,1024,1025,1026,1027,1028,1029,1030,1031,1032,1033,1034,1035,1036,1037,1038,1039,1040,1041,1042,1043,1044,1045,1046,1047,1048,1049,1050,1051,1052,1053,1054,1055,1056,1057,1058,1059,1060,1061,1062,1063,1064,1065,1066,1067,1068,1069,1070,1071,1072,1073,1074,1075,1076,1077,1078,1079],{"trials":1909,"activeCount":67},[],{"trials":1911,"activeCount":67},[],{"intervention":1030,"totalTrials":63,"cells":1913},{"EARLY_PHASE1":1914,"PHASE1":1916,"PHASE2":1918,"PHASE3":1920,"PHASE4":1926,"NA":1928},{"trials":1915,"activeCount":67},[],{"trials":1917,"activeCount":67},[],{"trials":1919,"activeCount":67},[],{"trials":1921,"activeCount":67},[1922],{"nctId":972,"briefTitle":973,"status":166,"phases":1923,"primaryCompletion":975,"completion":975,"start":976,"enrollment":977,"conditions":1924,"interventions":1925},[58],[979,980,954,981,982],[961,984,985,986,987,988,989,990,991,992,993,994,995,996,997,998,999,1000,1001,1002,1003,1004,1005,1006,1007,1008,1009,1010,1011,1012,1013,1014,1015,1016,1017,1018,1019,1020,1021,1022,1023,1024,1025,1026,1027,1028,1029,1030,1031,1032,1033,1034,1035,1036,1037,1038,1039,1040,1041,1042,1043,1044,1045,1046,1047,1048,1049,1050,1051,1052,1053,1054,1055,1056,1057,1058,1059,1060,1061,1062,1063,1064,1065,1066,1067,1068,1069,1070,1071,1072,1073,1074,1075,1076,1077,1078,1079],{"trials":1927,"activeCount":67},[],{"trials":1929,"activeCount":67},[],{"intervention":1031,"totalTrials":63,"cells":1931},{"EARLY_PHASE1":1932,"PHASE1":1934,"PHASE2":1936,"PHASE3":1938,"PHASE4":1944,"NA":1946},{"trials":1933,"activeCount":67},[],{"trials":1935,"activeCount":67},[],{"trials":1937,"activeCount":67},[],{"trials":1939,"activeCount":67},[1940],{"nctId":972,"briefTitle":973,"status":166,"phases":1941,"primaryCompletion":975,"completion":975,"start":976,"enrollment":977,"conditions":1942,"interventions":1943},[58],[979,980,954,981,982],[961,984,985,986,987,988,989,990,991,992,993,994,995,996,997,998,999,1000,1001,1002,1003,1004,1005,1006,1007,1008,1009,1010,1011,1012,1013,1014,1015,1016,1017,1018,1019,1020,1021,1022,1023,1024,1025,1026,1027,1028,1029,1030,1031,1032,1033,1034,1035,1036,1037,1038,1039,1040,1041,1042,1043,1044,1045,1046,1047,1048,1049,1050,1051,1052,1053,1054,1055,1056,1057,1058,1059,1060,1061,1062,1063,1064,1065,1066,1067,1068,1069,1070,1071,1072,1073,1074,1075,1076,1077,1078,1079],{"trials":1945,"activeCount":67},[],{"trials":1947,"activeCount":67},[],{"intervention":1032,"totalTrials":63,"cells":1949},{"EARLY_PHASE1":1950,"PHASE1":1952,"PHASE2":1954,"PHASE3":1956,"PHASE4":1962,"NA":1964},{"trials":1951,"activeCount":67},[],{"trials":1953,"activeCount":67},[],{"trials":1955,"activeCount":67},[],{"trials":1957,"activeCount":67},[1958],{"nctId":972,"briefTitle":973,"status":166,"phases":1959,"primaryCompletion":975,"completion":975,"start":976,"enrollment":977,"conditions":1960,"interventions":1961},[58],[979,980,954,981,982],[961,984,985,986,987,988,989,990,991,992,993,994,995,996,997,998,999,1000,1001,1002,1003,1004,1005,1006,1007,1008,1009,1010,1011,1012,1013,1014,1015,1016,1017,1018,1019,1020,1021,1022,1023,1024,1025,1026,1027,1028,1029,1030,1031,1032,1033,1034,1035,1036,1037,1038,1039,1040,1041,1042,1043,1044,1045,1046,1047,1048,1049,1050,1051,1052,1053,1054,1055,1056,1057,1058,1059,1060,1061,1062,1063,1064,1065,1066,1067,1068,1069,1070,1071,1072,1073,1074,1075,1076,1077,1078,1079],{"trials":1963,"activeCount":67},[],{"trials":1965,"activeCount":67},[],{"intervention":1033,"totalTrials":63,"cells":1967},{"EARLY_PHASE1":1968,"PHASE1":1970,"PHASE2":1972,"PHASE3":1974,"PHASE4":1980,"NA":1982},{"trials":1969,"activeCount":67},[],{"trials":1971,"activeCount":67},[],{"trials":1973,"activeCount":67},[],{"trials":1975,"activeCount":67},[1976],{"nctId":972,"briefTitle":973,"status":166,"phases":1977,"primaryCompletion":975,"completion":975,"start":976,"enrollment":977,"conditions":1978,"interventions":1979},[58],[979,980,954,981,982],[961,984,985,986,987,988,989,990,991,992,993,994,995,996,997,998,999,1000,1001,1002,1003,1004,1005,1006,1007,1008,1009,1010,1011,1012,1013,1014,1015,1016,1017,1018,1019,1020,1021,1022,1023,1024,1025,1026,1027,1028,1029,1030,1031,1032,1033,1034,1035,1036,1037,1038,1039,1040,1041,1042,1043,1044,1045,1046,1047,1048,1049,1050,1051,1052,1053,1054,1055,1056,1057,1058,1059,1060,1061,1062,1063,1064,1065,1066,1067,1068,1069,1070,1071,1072,1073,1074,1075,1076,1077,1078,1079],{"trials":1981,"activeCount":67},[],{"trials":1983,"activeCount":67},[],{"intervention":1034,"totalTrials":63,"cells":1985},{"EARLY_PHASE1":1986,"PHASE1":1988,"PHASE2":1990,"PHASE3":1992,"PHASE4":1998,"NA":2000},{"trials":1987,"activeCount":67},[],{"trials":1989,"activeCount":67},[],{"trials":1991,"activeCount":67},[],{"trials":1993,"activeCount":67},[1994],{"nctId":972,"briefTitle":973,"status":166,"phases":1995,"primaryCompletion":975,"completion":975,"start":976,"enrollment":977,"conditions":1996,"interventions":1997},[58],[979,980,954,981,982],[961,984,985,986,987,988,989,990,991,992,993,994,995,996,997,998,999,1000,1001,1002,1003,1004,1005,1006,1007,1008,1009,1010,1011,1012,1013,1014,1015,1016,1017,1018,1019,1020,1021,1022,1023,1024,1025,1026,1027,1028,1029,1030,1031,1032,1033,1034,1035,1036,1037,1038,1039,1040,1041,1042,1043,1044,1045,1046,1047,1048,1049,1050,1051,1052,1053,1054,1055,1056,1057,1058,1059,1060,1061,1062,1063,1064,1065,1066,1067,1068,1069,1070,1071,1072,1073,1074,1075,1076,1077,1078,1079],{"trials":1999,"activeCount":67},[],{"trials":2001,"activeCount":67},[],{"intervention":1035,"totalTrials":63,"cells":2003},{"EARLY_PHASE1":2004,"PHASE1":2006,"PHASE2":2008,"PHASE3":2010,"PHASE4":2016,"NA":2018},{"trials":2005,"activeCount":67},[],{"trials":2007,"activeCount":67},[],{"trials":2009,"activeCount":67},[],{"trials":2011,"activeCount":67},[2012],{"nctId":972,"briefTitle":973,"status":166,"phases":2013,"primaryCompletion":975,"completion":975,"start":976,"enrollment":977,"conditions":2014,"interventions":2015},[58],[979,980,954,981,982],[961,984,985,986,987,988,989,990,991,992,993,994,995,996,997,998,999,1000,1001,1002,1003,1004,1005,1006,1007,1008,1009,1010,1011,1012,1013,1014,1015,1016,1017,1018,1019,1020,1021,1022,1023,1024,1025,1026,1027,1028,1029,1030,1031,1032,1033,1034,1035,1036,1037,1038,1039,1040,1041,1042,1043,1044,1045,1046,1047,1048,1049,1050,1051,1052,1053,1054,1055,1056,1057,1058,1059,1060,1061,1062,1063,1064,1065,1066,1067,1068,1069,1070,1071,1072,1073,1074,1075,1076,1077,1078,1079],{"trials":2017,"activeCount":67},[],{"trials":2019,"activeCount":67},[],{"intervention":1036,"totalTrials":63,"cells":2021},{"EARLY_PHASE1":2022,"PHASE1":2024,"PHASE2":2026,"PHASE3":2028,"PHASE4":2034,"NA":2036},{"trials":2023,"activeCount":67},[],{"trials":2025,"activeCount":67},[],{"trials":2027,"activeCount":67},[],{"trials":2029,"activeCount":67},[2030],{"nctId":972,"briefTitle":973,"status":166,"phases":2031,"primaryCompletion":975,"completion":975,"start":976,"enrollment":977,"conditions":2032,"interventions":2033},[58],[979,980,954,981,982],[961,984,985,986,987,988,989,990,991,992,993,994,995,996,997,998,999,1000,1001,1002,1003,1004,1005,1006,1007,1008,1009,1010,1011,1012,1013,1014,1015,1016,1017,1018,1019,1020,1021,1022,1023,1024,1025,1026,1027,1028,1029,1030,1031,1032,1033,1034,1035,1036,1037,1038,1039,1040,1041,1042,1043,1044,1045,1046,1047,1048,1049,1050,1051,1052,1053,1054,1055,1056,1057,1058,1059,1060,1061,1062,1063,1064,1065,1066,1067,1068,1069,1070,1071,1072,1073,1074,1075,1076,1077,1078,1079],{"trials":2035,"activeCount":67},[],{"trials":2037,"activeCount":67},[],{"intervention":1037,"totalTrials":63,"cells":2039},{"EARLY_PHASE1":2040,"PHASE1":2042,"PHASE2":2044,"PHASE3":2046,"PHASE4":2052,"NA":2054},{"trials":2041,"activeCount":67},[],{"trials":2043,"activeCount":67},[],{"trials":2045,"activeCount":67},[],{"trials":2047,"activeCount":67},[2048],{"nctId":972,"briefTitle":973,"status":166,"phases":2049,"primaryCompletion":975,"completion":975,"start":976,"enrollment":977,"conditions":2050,"interventions":2051},[58],[979,980,954,981,982],[961,984,985,986,987,988,989,990,991,992,993,994,995,996,997,998,999,1000,1001,1002,1003,1004,1005,1006,1007,1008,1009,1010,1011,1012,1013,1014,1015,1016,1017,1018,1019,1020,1021,1022,1023,1024,1025,1026,1027,1028,1029,1030,1031,1032,1033,1034,1035,1036,1037,1038,1039,1040,1041,1042,1043,1044,1045,1046,1047,1048,1049,1050,1051,1052,1053,1054,1055,1056,1057,1058,1059,1060,1061,1062,1063,1064,1065,1066,1067,1068,1069,1070,1071,1072,1073,1074,1075,1076,1077,1078,1079],{"trials":2053,"activeCount":67},[],{"trials":2055,"activeCount":67},[],{"intervention":1038,"totalTrials":63,"cells":2057},{"EARLY_PHASE1":2058,"PHASE1":2060,"PHASE2":2062,"PHASE3":2064,"PHASE4":2070,"NA":2072},{"trials":2059,"activeCount":67},[],{"trials":2061,"activeCount":67},[],{"trials":2063,"activeCount":67},[],{"trials":2065,"activeCount":67},[2066],{"nctId":972,"briefTitle":973,"status":166,"phases":2067,"primaryCompletion":975,"completion":975,"start":976,"enrollment":977,"conditions":2068,"interventions":2069},[58],[979,980,954,981,982],[961,984,985,986,987,988,989,990,991,992,993,994,995,996,997,998,999,1000,1001,1002,1003,1004,1005,1006,1007,1008,1009,1010,1011,1012,1013,1014,1015,1016,1017,1018,1019,1020,1021,1022,1023,1024,1025,1026,1027,1028,1029,1030,1031,1032,1033,1034,1035,1036,1037,1038,1039,1040,1041,1042,1043,1044,1045,1046,1047,1048,1049,1050,1051,1052,1053,1054,1055,1056,1057,1058,1059,1060,1061,1062,1063,1064,1065,1066,1067,1068,1069,1070,1071,1072,1073,1074,1075,1076,1077,1078,1079],{"trials":2071,"activeCount":67},[],{"trials":2073,"activeCount":67},[],{"intervention":1039,"totalTrials":63,"cells":2075},{"EARLY_PHASE1":2076,"PHASE1":2078,"PHASE2":2080,"PHASE3":2082,"PHASE4":2088,"NA":2090},{"trials":2077,"activeCount":67},[],{"trials":2079,"activeCount":67},[],{"trials":2081,"activeCount":67},[],{"trials":2083,"activeCount":67},[2084],{"nctId":972,"briefTitle":973,"status":166,"phases":2085,"primaryCompletion":975,"completion":975,"start":976,"enrollment":977,"conditions":2086,"interventions":2087},[58],[979,980,954,981,982],[961,984,985,986,987,988,989,990,991,992,993,994,995,996,997,998,999,1000,1001,1002,1003,1004,1005,1006,1007,1008,1009,1010,1011,1012,1013,1014,1015,1016,1017,1018,1019,1020,1021,1022,1023,1024,1025,1026,1027,1028,1029,1030,1031,1032,1033,1034,1035,1036,1037,1038,1039,1040,1041,1042,1043,1044,1045,1046,1047,1048,1049,1050,1051,1052,1053,1054,1055,1056,1057,1058,1059,1060,1061,1062,1063,1064,1065,1066,1067,1068,1069,1070,1071,1072,1073,1074,1075,1076,1077,1078,1079],{"trials":2089,"activeCount":67},[],{"trials":2091,"activeCount":67},[],{"intervention":1040,"totalTrials":63,"cells":2093},{"EARLY_PHASE1":2094,"PHASE1":2096,"PHASE2":2098,"PHASE3":2100,"PHASE4":2106,"NA":2108},{"trials":2095,"activeCount":67},[],{"trials":2097,"activeCount":67},[],{"trials":2099,"activeCount":67},[],{"trials":2101,"activeCount":67},[2102],{"nctId":972,"briefTitle":973,"status":166,"phases":2103,"primaryCompletion":975,"completion":975,"start":976,"enrollment":977,"conditions":2104,"interventions":2105},[58],[979,980,954,981,982],[961,984,985,986,987,988,989,990,991,992,993,994,995,996,997,998,999,1000,1001,1002,1003,1004,1005,1006,1007,1008,1009,1010,1011,1012,1013,1014,1015,1016,1017,1018,1019,1020,1021,1022,1023,1024,1025,1026,1027,1028,1029,1030,1031,1032,1033,1034,1035,1036,1037,1038,1039,1040,1041,1042,1043,1044,1045,1046,1047,1048,1049,1050,1051,1052,1053,1054,1055,1056,1057,1058,1059,1060,1061,1062,1063,1064,1065,1066,1067,1068,1069,1070,1071,1072,1073,1074,1075,1076,1077,1078,1079],{"trials":2107,"activeCount":67},[],{"trials":2109,"activeCount":67},[],{"intervention":1041,"totalTrials":63,"cells":2111},{"EARLY_PHASE1":2112,"PHASE1":2114,"PHASE2":2116,"PHASE3":2118,"PHASE4":2124,"NA":2126},{"trials":2113,"activeCount":67},[],{"trials":2115,"activeCount":67},[],{"trials":2117,"activeCount":67},[],{"trials":2119,"activeCount":67},[2120],{"nctId":972,"briefTitle":973,"status":166,"phases":2121,"primaryCompletion":975,"completion":975,"start":976,"enrollment":977,"conditions":2122,"interventions":2123},[58],[979,980,954,981,982],[961,984,985,986,987,988,989,990,991,992,993,994,995,996,997,998,999,1000,1001,1002,1003,1004,1005,1006,1007,1008,1009,1010,1011,1012,1013,1014,1015,1016,1017,1018,1019,1020,1021,1022,1023,1024,1025,1026,1027,1028,1029,1030,1031,1032,1033,1034,1035,1036,1037,1038,1039,1040,1041,1042,1043,1044,1045,1046,1047,1048,1049,1050,1051,1052,1053,1054,1055,1056,1057,1058,1059,1060,1061,1062,1063,1064,1065,1066,1067,1068,1069,1070,1071,1072,1073,1074,1075,1076,1077,1078,1079],{"trials":2125,"activeCount":67},[],{"trials":2127,"activeCount":67},[],{"intervention":1042,"totalTrials":63,"cells":2129},{"EARLY_PHASE1":2130,"PHASE1":2132,"PHASE2":2134,"PHASE3":2136,"PHASE4":2142,"NA":2144},{"trials":2131,"activeCount":67},[],{"trials":2133,"activeCount":67},[],{"trials":2135,"activeCount":67},[],{"trials":2137,"activeCount":67},[2138],{"nctId":972,"briefTitle":973,"status":166,"phases":2139,"primaryCompletion":975,"completion":975,"start":976,"enrollment":977,"conditions":2140,"interventions":2141},[58],[979,980,954,981,982],[961,984,985,986,987,988,989,990,991,992,993,994,995,996,997,998,999,1000,1001,1002,1003,1004,1005,1006,1007,1008,1009,1010,1011,1012,1013,1014,1015,1016,1017,1018,1019,1020,1021,1022,1023,1024,1025,1026,1027,1028,1029,1030,1031,1032,1033,1034,1035,1036,1037,1038,1039,1040,1041,1042,1043,1044,1045,1046,1047,1048,1049,1050,1051,1052,1053,1054,1055,1056,1057,1058,1059,1060,1061,1062,1063,1064,1065,1066,1067,1068,1069,1070,1071,1072,1073,1074,1075,1076,1077,1078,1079],{"trials":2143,"activeCount":67},[],{"trials":2145,"activeCount":67},[],{"intervention":1043,"totalTrials":63,"cells":2147},{"EARLY_PHASE1":2148,"PHASE1":2150,"PHASE2":2152,"PHASE3":2154,"PHASE4":2160,"NA":2162},{"trials":2149,"activeCount":67},[],{"trials":2151,"activeCount":67},[],{"trials":2153,"activeCount":67},[],{"trials":2155,"activeCount":67},[2156],{"nctId":972,"briefTitle":973,"status":166,"phases":2157,"primaryCompletion":975,"completion":975,"start":976,"enrollment":977,"conditions":2158,"interventions":2159},[58],[979,980,954,981,982],[961,984,985,986,987,988,989,990,991,992,993,994,995,996,997,998,999,1000,1001,1002,1003,1004,1005,1006,1007,1008,1009,1010,1011,1012,1013,1014,1015,1016,1017,1018,1019,1020,1021,1022,1023,1024,1025,1026,1027,1028,1029,1030,1031,1032,1033,1034,1035,1036,1037,1038,1039,1040,1041,1042,1043,1044,1045,1046,1047,1048,1049,1050,1051,1052,1053,1054,1055,1056,1057,1058,1059,1060,1061,1062,1063,1064,1065,1066,1067,1068,1069,1070,1071,1072,1073,1074,1075,1076,1077,1078,1079],{"trials":2161,"activeCount":67},[],{"trials":2163,"activeCount":67},[],{"intervention":1044,"totalTrials":63,"cells":2165},{"EARLY_PHASE1":2166,"PHASE1":2168,"PHASE2":2170,"PHASE3":2172,"PHASE4":2178,"NA":2180},{"trials":2167,"activeCount":67},[],{"trials":2169,"activeCount":67},[],{"trials":2171,"activeCount":67},[],{"trials":2173,"activeCount":67},[2174],{"nctId":972,"briefTitle":973,"status":166,"phases":2175,"primaryCompletion":975,"completion":975,"start":976,"enrollment":977,"conditions":2176,"interventions":2177},[58],[979,980,954,981,982],[961,984,985,986,987,988,989,990,991,992,993,994,995,996,997,998,999,1000,1001,1002,1003,1004,1005,1006,1007,1008,1009,1010,1011,1012,1013,1014,1015,1016,1017,1018,1019,1020,1021,1022,1023,1024,1025,1026,1027,1028,1029,1030,1031,1032,1033,1034,1035,1036,1037,1038,1039,1040,1041,1042,1043,1044,1045,1046,1047,1048,1049,1050,1051,1052,1053,1054,1055,1056,1057,1058,1059,1060,1061,1062,1063,1064,1065,1066,1067,1068,1069,1070,1071,1072,1073,1074,1075,1076,1077,1078,1079],{"trials":2179,"activeCount":67},[],{"trials":2181,"activeCount":67},[],{"intervention":1045,"totalTrials":63,"cells":2183},{"EARLY_PHASE1":2184,"PHASE1":2186,"PHASE2":2188,"PHASE3":2190,"PHASE4":2196,"NA":2198},{"trials":2185,"activeCount":67},[],{"trials":2187,"activeCount":67},[],{"trials":2189,"activeCount":67},[],{"trials":2191,"activeCount":67},[2192],{"nctId":972,"briefTitle":973,"status":166,"phases":2193,"primaryCompletion":975,"completion":975,"start":976,"enrollment":977,"conditions":2194,"interventions":2195},[58],[979,980,954,981,982],[961,984,985,986,987,988,989,990,991,992,993,994,995,996,997,998,999,1000,1001,1002,1003,1004,1005,1006,1007,1008,1009,1010,1011,1012,1013,1014,1015,1016,1017,1018,1019,1020,1021,1022,1023,1024,1025,1026,1027,1028,1029,1030,1031,1032,1033,1034,1035,1036,1037,1038,1039,1040,1041,1042,1043,1044,1045,1046,1047,1048,1049,1050,1051,1052,1053,1054,1055,1056,1057,1058,1059,1060,1061,1062,1063,1064,1065,1066,1067,1068,1069,1070,1071,1072,1073,1074,1075,1076,1077,1078,1079],{"trials":2197,"activeCount":67},[],{"trials":2199,"activeCount":67},[],{"intervention":1046,"totalTrials":63,"cells":2201},{"EARLY_PHASE1":2202,"PHASE1":2204,"PHASE2":2206,"PHASE3":2208,"PHASE4":2214,"NA":2216},{"trials":2203,"activeCount":67},[],{"trials":2205,"activeCount":67},[],{"trials":2207,"activeCount":67},[],{"trials":2209,"activeCount":67},[2210],{"nctId":972,"briefTitle":973,"status":166,"phases":2211,"primaryCompletion":975,"completion":975,"start":976,"enrollment":977,"conditions":2212,"interventions":2213},[58],[979,980,954,981,982],[961,984,985,986,987,988,989,990,991,992,993,994,995,996,997,998,999,1000,1001,1002,1003,1004,1005,1006,1007,1008,1009,1010,1011,1012,1013,1014,1015,1016,1017,1018,1019,1020,1021,1022,1023,1024,1025,1026,1027,1028,1029,1030,1031,1032,1033,1034,1035,1036,1037,1038,1039,1040,1041,1042,1043,1044,1045,1046,1047,1048,1049,1050,1051,1052,1053,1054,1055,1056,1057,1058,1059,1060,1061,1062,1063,1064,1065,1066,1067,1068,1069,1070,1071,1072,1073,1074,1075,1076,1077,1078,1079],{"trials":2215,"activeCount":67},[],{"trials":2217,"activeCount":67},[],{"intervention":1047,"totalTrials":63,"cells":2219},{"EARLY_PHASE1":2220,"PHASE1":2222,"PHASE2":2224,"PHASE3":2226,"PHASE4":2232,"NA":2234},{"trials":2221,"activeCount":67},[],{"trials":2223,"activeCount":67},[],{"trials":2225,"activeCount":67},[],{"trials":2227,"activeCount":67},[2228],{"nctId":972,"briefTitle":973,"status":166,"phases":2229,"primaryCompletion":975,"completion":975,"start":976,"enrollment":977,"conditions":2230,"interventions":2231},[58],[979,980,954,981,982],[961,984,985,986,987,988,989,990,991,992,993,994,995,996,997,998,999,1000,1001,1002,1003,1004,1005,1006,1007,1008,1009,1010,1011,1012,1013,1014,1015,1016,1017,1018,1019,1020,1021,1022,1023,1024,1025,1026,1027,1028,1029,1030,1031,1032,1033,1034,1035,1036,1037,1038,1039,1040,1041,1042,1043,1044,1045,1046,1047,1048,1049,1050,1051,1052,1053,1054,1055,1056,1057,1058,1059,1060,1061,1062,1063,1064,1065,1066,1067,1068,1069,1070,1071,1072,1073,1074,1075,1076,1077,1078,1079],{"trials":2233,"activeCount":67},[],{"trials":2235,"activeCount":67},[],{"intervention":1048,"totalTrials":63,"cells":2237},{"EARLY_PHASE1":2238,"PHASE1":2240,"PHASE2":2242,"PHASE3":2244,"PHASE4":2250,"NA":2252},{"trials":2239,"activeCount":67},[],{"trials":2241,"activeCount":67},[],{"trials":2243,"activeCount":67},[],{"trials":2245,"activeCount":67},[2246],{"nctId":972,"briefTitle":973,"status":166,"phases":2247,"primaryCompletion":975,"completion":975,"start":976,"enrollment":977,"conditions":2248,"interventions":2249},[58],[979,980,954,981,982],[961,984,985,986,987,988,989,990,991,992,993,994,995,996,997,998,999,1000,1001,1002,1003,1004,1005,1006,1007,1008,1009,1010,1011,1012,1013,1014,1015,1016,1017,1018,1019,1020,1021,1022,1023,1024,1025,1026,1027,1028,1029,1030,1031,1032,1033,1034,1035,1036,1037,1038,1039,1040,1041,1042,1043,1044,1045,1046,1047,1048,1049,1050,1051,1052,1053,1054,1055,1056,1057,1058,1059,1060,1061,1062,1063,1064,1065,1066,1067,1068,1069,1070,1071,1072,1073,1074,1075,1076,1077,1078,1079],{"trials":2251,"activeCount":67},[],{"trials":2253,"activeCount":67},[],{"intervention":1049,"totalTrials":63,"cells":2255},{"EARLY_PHASE1":2256,"PHASE1":2258,"PHASE2":2260,"PHASE3":2262,"PHASE4":2268,"NA":2270},{"trials":2257,"activeCount":67},[],{"trials":2259,"activeCount":67},[],{"trials":2261,"activeCount":67},[],{"trials":2263,"activeCount":67},[2264],{"nctId":972,"briefTitle":973,"status":166,"phases":2265,"primaryCompletion":975,"completion":975,"start":976,"enrollment":977,"conditions":2266,"interventions":2267},[58],[979,980,954,981,982],[961,984,985,986,987,988,989,990,991,992,993,994,995,996,997,998,999,1000,1001,1002,1003,1004,1005,1006,1007,1008,1009,1010,1011,1012,1013,1014,1015,1016,1017,1018,1019,1020,1021,1022,1023,1024,1025,1026,1027,1028,1029,1030,1031,1032,1033,1034,1035,1036,1037,1038,1039,1040,1041,1042,1043,1044,1045,1046,1047,1048,1049,1050,1051,1052,1053,1054,1055,1056,1057,1058,1059,1060,1061,1062,1063,1064,1065,1066,1067,1068,1069,1070,1071,1072,1073,1074,1075,1076,1077,1078,1079],{"trials":2269,"activeCount":67},[],{"trials":2271,"activeCount":67},[],{"intervention":1050,"totalTrials":63,"cells":2273},{"EARLY_PHASE1":2274,"PHASE1":2276,"PHASE2":2278,"PHASE3":2280,"PHASE4":2286,"NA":2288},{"trials":2275,"activeCount":67},[],{"trials":2277,"activeCount":67},[],{"trials":2279,"activeCount":67},[],{"trials":2281,"activeCount":67},[2282],{"nctId":972,"briefTitle":973,"status":166,"phases":2283,"primaryCompletion":975,"completion":975,"start":976,"enrollment":977,"conditions":2284,"interventions":2285},[58],[979,980,954,981,982],[961,984,985,986,987,988,989,990,991,992,993,994,995,996,997,998,999,1000,1001,1002,1003,1004,1005,1006,1007,1008,1009,1010,1011,1012,1013,1014,1015,1016,1017,1018,1019,1020,1021,1022,1023,1024,1025,1026,1027,1028,1029,1030,1031,1032,1033,1034,1035,1036,1037,1038,1039,1040,1041,1042,1043,1044,1045,1046,1047,1048,1049,1050,1051,1052,1053,1054,1055,1056,1057,1058,1059,1060,1061,1062,1063,1064,1065,1066,1067,1068,1069,1070,1071,1072,1073,1074,1075,1076,1077,1078,1079],{"trials":2287,"activeCount":67},[],{"trials":2289,"activeCount":67},[],{"intervention":1051,"totalTrials":63,"cells":2291},{"EARLY_PHASE1":2292,"PHASE1":2294,"PHASE2":2296,"PHASE3":2298,"PHASE4":2304,"NA":2306},{"trials":2293,"activeCount":67},[],{"trials":2295,"activeCount":67},[],{"trials":2297,"activeCount":67},[],{"trials":2299,"activeCount":67},[2300],{"nctId":972,"briefTitle":973,"status":166,"phases":2301,"primaryCompletion":975,"completion":975,"start":976,"enrollment":977,"conditions":2302,"interventions":2303},[58],[979,980,954,981,982],[961,984,985,986,987,988,989,990,991,992,993,994,995,996,997,998,999,1000,1001,1002,1003,1004,1005,1006,1007,1008,1009,1010,1011,1012,1013,1014,1015,1016,1017,1018,1019,1020,1021,1022,1023,1024,1025,1026,1027,1028,1029,1030,1031,1032,1033,1034,1035,1036,1037,1038,1039,1040,1041,1042,1043,1044,1045,1046,1047,1048,1049,1050,1051,1052,1053,1054,1055,1056,1057,1058,1059,1060,1061,1062,1063,1064,1065,1066,1067,1068,1069,1070,1071,1072,1073,1074,1075,1076,1077,1078,1079],{"trials":2305,"activeCount":67},[],{"trials":2307,"activeCount":67},[],{"intervention":1052,"totalTrials":63,"cells":2309},{"EARLY_PHASE1":2310,"PHASE1":2312,"PHASE2":2314,"PHASE3":2316,"PHASE4":2322,"NA":2324},{"trials":2311,"activeCount":67},[],{"trials":2313,"activeCount":67},[],{"trials":2315,"activeCount":67},[],{"trials":2317,"activeCount":67},[2318],{"nctId":972,"briefTitle":973,"status":166,"phases":2319,"primaryCompletion":975,"completion":975,"start":976,"enrollment":977,"conditions":2320,"interventions":2321},[58],[979,980,954,981,982],[961,984,985,986,987,988,989,990,991,992,993,994,995,996,997,998,999,1000,1001,1002,1003,1004,1005,1006,1007,1008,1009,1010,1011,1012,1013,1014,1015,1016,1017,1018,1019,1020,1021,1022,1023,1024,1025,1026,1027,1028,1029,1030,1031,1032,1033,1034,1035,1036,1037,1038,1039,1040,1041,1042,1043,1044,1045,1046,1047,1048,1049,1050,1051,1052,1053,1054,1055,1056,1057,1058,1059,1060,1061,1062,1063,1064,1065,1066,1067,1068,1069,1070,1071,1072,1073,1074,1075,1076,1077,1078,1079],{"trials":2323,"activeCount":67},[],{"trials":2325,"activeCount":67},[],{"intervention":1053,"totalTrials":63,"cells":2327},{"EARLY_PHASE1":2328,"PHASE1":2330,"PHASE2":2332,"PHASE3":2334,"PHASE4":2340,"NA":2342},{"trials":2329,"activeCount":67},[],{"trials":2331,"activeCount":67},[],{"trials":2333,"activeCount":67},[],{"trials":2335,"activeCount":67},[2336],{"nctId":972,"briefTitle":973,"status":166,"phases":2337,"primaryCompletion":975,"completion":975,"start":976,"enrollment":977,"conditions":2338,"interventions":2339},[58],[979,980,954,981,982],[961,984,985,986,987,988,989,990,991,992,993,994,995,996,997,998,999,1000,1001,1002,1003,1004,1005,1006,1007,1008,1009,1010,1011,1012,1013,1014,1015,1016,1017,1018,1019,1020,1021,1022,1023,1024,1025,1026,1027,1028,1029,1030,1031,1032,1033,1034,1035,1036,1037,1038,1039,1040,1041,1042,1043,1044,1045,1046,1047,1048,1049,1050,1051,1052,1053,1054,1055,1056,1057,1058,1059,1060,1061,1062,1063,1064,1065,1066,1067,1068,1069,1070,1071,1072,1073,1074,1075,1076,1077,1078,1079],{"trials":2341,"activeCount":67},[],{"trials":2343,"activeCount":67},[],{"intervention":1054,"totalTrials":63,"cells":2345},{"EARLY_PHASE1":2346,"PHASE1":2348,"PHASE2":2350,"PHASE3":2352,"PHASE4":2358,"NA":2360},{"trials":2347,"activeCount":67},[],{"trials":2349,"activeCount":67},[],{"trials":2351,"activeCount":67},[],{"trials":2353,"activeCount":67},[2354],{"nctId":972,"briefTitle":973,"status":166,"phases":2355,"primaryCompletion":975,"completion":975,"start":976,"enrollment":977,"conditions":2356,"interventions":2357},[58],[979,980,954,981,982],[961,984,985,986,987,988,989,990,991,992,993,994,995,996,997,998,999,1000,1001,1002,1003,1004,1005,1006,1007,1008,1009,1010,1011,1012,1013,1014,1015,1016,1017,1018,1019,1020,1021,1022,1023,1024,1025,1026,1027,1028,1029,1030,1031,1032,1033,1034,1035,1036,1037,1038,1039,1040,1041,1042,1043,1044,1045,1046,1047,1048,1049,1050,1051,1052,1053,1054,1055,1056,1057,1058,1059,1060,1061,1062,1063,1064,1065,1066,1067,1068,1069,1070,1071,1072,1073,1074,1075,1076,1077,1078,1079],{"trials":2359,"activeCount":67},[],{"trials":2361,"activeCount":67},[],{"intervention":1055,"totalTrials":63,"cells":2363},{"EARLY_PHASE1":2364,"PHASE1":2366,"PHASE2":2368,"PHASE3":2370,"PHASE4":2376,"NA":2378},{"trials":2365,"activeCount":67},[],{"trials":2367,"activeCount":67},[],{"trials":2369,"activeCount":67},[],{"trials":2371,"activeCount":67},[2372],{"nctId":972,"briefTitle":973,"status":166,"phases":2373,"primaryCompletion":975,"completion":975,"start":976,"enrollment":977,"conditions":2374,"interventions":2375},[58],[979,980,954,981,982],[961,984,985,986,987,988,989,990,991,992,993,994,995,996,997,998,999,1000,1001,1002,1003,1004,1005,1006,1007,1008,1009,1010,1011,1012,1013,1014,1015,1016,1017,1018,1019,1020,1021,1022,1023,1024,1025,1026,1027,1028,1029,1030,1031,1032,1033,1034,1035,1036,1037,1038,1039,1040,1041,1042,1043,1044,1045,1046,1047,1048,1049,1050,1051,1052,1053,1054,1055,1056,1057,1058,1059,1060,1061,1062,1063,1064,1065,1066,1067,1068,1069,1070,1071,1072,1073,1074,1075,1076,1077,1078,1079],{"trials":2377,"activeCount":67},[],{"trials":2379,"activeCount":67},[],{"intervention":1056,"totalTrials":63,"cells":2381},{"EARLY_PHASE1":2382,"PHASE1":2384,"PHASE2":2386,"PHASE3":2388,"PHASE4":2394,"NA":2396},{"trials":2383,"activeCount":67},[],{"trials":2385,"activeCount":67},[],{"trials":2387,"activeCount":67},[],{"trials":2389,"activeCount":67},[2390],{"nctId":972,"briefTitle":973,"status":166,"phases":2391,"primaryCompletion":975,"completion":975,"start":976,"enrollment":977,"conditions":2392,"interventions":2393},[58],[979,980,954,981,982],[961,984,985,986,987,988,989,990,991,992,993,994,995,996,997,998,999,1000,1001,1002,1003,1004,1005,1006,1007,1008,1009,1010,1011,1012,1013,1014,1015,1016,1017,1018,1019,1020,1021,1022,1023,1024,1025,1026,1027,1028,1029,1030,1031,1032,1033,1034,1035,1036,1037,1038,1039,1040,1041,1042,1043,1044,1045,1046,1047,1048,1049,1050,1051,1052,1053,1054,1055,1056,1057,1058,1059,1060,1061,1062,1063,1064,1065,1066,1067,1068,1069,1070,1071,1072,1073,1074,1075,1076,1077,1078,1079],{"trials":2395,"activeCount":67},[],{"trials":2397,"activeCount":67},[],{"intervention":1057,"totalTrials":63,"cells":2399},{"EARLY_PHASE1":2400,"PHASE1":2402,"PHASE2":2404,"PHASE3":2406,"PHASE4":2412,"NA":2414},{"trials":2401,"activeCount":67},[],{"trials":2403,"activeCount":67},[],{"trials":2405,"activeCount":67},[],{"trials":2407,"activeCount":67},[2408],{"nctId":972,"briefTitle":973,"status":166,"phases":2409,"primaryCompletion":975,"completion":975,"start":976,"enrollment":977,"conditions":2410,"interventions":2411},[58],[979,980,954,981,982],[961,984,985,986,987,988,989,990,991,992,993,994,995,996,997,998,999,1000,1001,1002,1003,1004,1005,1006,1007,1008,1009,1010,1011,1012,1013,1014,1015,1016,1017,1018,1019,1020,1021,1022,1023,1024,1025,1026,1027,1028,1029,1030,1031,1032,1033,1034,1035,1036,1037,1038,1039,1040,1041,1042,1043,1044,1045,1046,1047,1048,1049,1050,1051,1052,1053,1054,1055,1056,1057,1058,1059,1060,1061,1062,1063,1064,1065,1066,1067,1068,1069,1070,1071,1072,1073,1074,1075,1076,1077,1078,1079],{"trials":2413,"activeCount":67},[],{"trials":2415,"activeCount":67},[],{"intervention":1058,"totalTrials":63,"cells":2417},{"EARLY_PHASE1":2418,"PHASE1":2420,"PHASE2":2422,"PHASE3":2424,"PHASE4":2430,"NA":2432},{"trials":2419,"activeCount":67},[],{"trials":2421,"activeCount":67},[],{"trials":2423,"activeCount":67},[],{"trials":2425,"activeCount":67},[2426],{"nctId":972,"briefTitle":973,"status":166,"phases":2427,"primaryCompletion":975,"completion":975,"start":976,"enrollment":977,"conditions":2428,"interventions":2429},[58],[979,980,954,981,982],[961,984,985,986,987,988,989,990,991,992,993,994,995,996,997,998,999,1000,1001,1002,1003,1004,1005,1006,1007,1008,1009,1010,1011,1012,1013,1014,1015,1016,1017,1018,1019,1020,1021,1022,1023,1024,1025,1026,1027,1028,1029,1030,1031,1032,1033,1034,1035,1036,1037,1038,1039,1040,1041,1042,1043,1044,1045,1046,1047,1048,1049,1050,1051,1052,1053,1054,1055,1056,1057,1058,1059,1060,1061,1062,1063,1064,1065,1066,1067,1068,1069,1070,1071,1072,1073,1074,1075,1076,1077,1078,1079],{"trials":2431,"activeCount":67},[],{"trials":2433,"activeCount":67},[],{"intervention":1059,"totalTrials":63,"cells":2435},{"EARLY_PHASE1":2436,"PHASE1":2438,"PHASE2":2440,"PHASE3":2442,"PHASE4":2448,"NA":2450},{"trials":2437,"activeCount":67},[],{"trials":2439,"activeCount":67},[],{"trials":2441,"activeCount":67},[],{"trials":2443,"activeCount":67},[2444],{"nctId":972,"briefTitle":973,"status":166,"phases":2445,"primaryCompletion":975,"completion":975,"start":976,"enrollment":977,"conditions":2446,"interventions":2447},[58],[979,980,954,981,982],[961,984,985,986,987,988,989,990,991,992,993,994,995,996,997,998,999,1000,1001,1002,1003,1004,1005,1006,1007,1008,1009,1010,1011,1012,1013,1014,1015,1016,1017,1018,1019,1020,1021,1022,1023,1024,1025,1026,1027,1028,1029,1030,1031,1032,1033,1034,1035,1036,1037,1038,1039,1040,1041,1042,1043,1044,1045,1046,1047,1048,1049,1050,1051,1052,1053,1054,1055,1056,1057,1058,1059,1060,1061,1062,1063,1064,1065,1066,1067,1068,1069,1070,1071,1072,1073,1074,1075,1076,1077,1078,1079],{"trials":2449,"activeCount":67},[],{"trials":2451,"activeCount":67},[],{"intervention":1060,"totalTrials":63,"cells":2453},{"EARLY_PHASE1":2454,"PHASE1":2456,"PHASE2":2458,"PHASE3":2460,"PHASE4":2466,"NA":2468},{"trials":2455,"activeCount":67},[],{"trials":2457,"activeCount":67},[],{"trials":2459,"activeCount":67},[],{"trials":2461,"activeCount":67},[2462],{"nctId":972,"briefTitle":973,"status":166,"phases":2463,"primaryCompletion":975,"completion":975,"start":976,"enrollment":977,"conditions":2464,"interventions":2465},[58],[979,980,954,981,982],[961,984,985,986,987,988,989,990,991,992,993,994,995,996,997,998,999,1000,1001,1002,1003,1004,1005,1006,1007,1008,1009,1010,1011,1012,1013,1014,1015,1016,1017,1018,1019,1020,1021,1022,1023,1024,1025,1026,1027,1028,1029,1030,1031,1032,1033,1034,1035,1036,1037,1038,1039,1040,1041,1042,1043,1044,1045,1046,1047,1048,1049,1050,1051,1052,1053,1054,1055,1056,1057,1058,1059,1060,1061,1062,1063,1064,1065,1066,1067,1068,1069,1070,1071,1072,1073,1074,1075,1076,1077,1078,1079],{"trials":2467,"activeCount":67},[],{"trials":2469,"activeCount":67},[],{"intervention":1061,"totalTrials":63,"cells":2471},{"EARLY_PHASE1":2472,"PHASE1":2474,"PHASE2":2476,"PHASE3":2478,"PHASE4":2484,"NA":2486},{"trials":2473,"activeCount":67},[],{"trials":2475,"activeCount":67},[],{"trials":2477,"activeCount":67},[],{"trials":2479,"activeCount":67},[2480],{"nctId":972,"briefTitle":973,"status":166,"phases":2481,"primaryCompletion":975,"completion":975,"start":976,"enrollment":977,"conditions":2482,"interventions":2483},[58],[979,980,954,981,982],[961,984,985,986,987,988,989,990,991,992,993,994,995,996,997,998,999,1000,1001,1002,1003,1004,1005,1006,1007,1008,1009,1010,1011,1012,1013,1014,1015,1016,1017,1018,1019,1020,1021,1022,1023,1024,1025,1026,1027,1028,1029,1030,1031,1032,1033,1034,1035,1036,1037,1038,1039,1040,1041,1042,1043,1044,1045,1046,1047,1048,1049,1050,1051,1052,1053,1054,1055,1056,1057,1058,1059,1060,1061,1062,1063,1064,1065,1066,1067,1068,1069,1070,1071,1072,1073,1074,1075,1076,1077,1078,1079],{"trials":2485,"activeCount":67},[],{"trials":2487,"activeCount":67},[],{"intervention":1062,"totalTrials":63,"cells":2489},{"EARLY_PHASE1":2490,"PHASE1":2492,"PHASE2":2494,"PHASE3":2496,"PHASE4":2502,"NA":2504},{"trials":2491,"activeCount":67},[],{"trials":2493,"activeCount":67},[],{"trials":2495,"activeCount":67},[],{"trials":2497,"activeCount":67},[2498],{"nctId":972,"briefTitle":973,"status":166,"phases":2499,"primaryCompletion":975,"completion":975,"start":976,"enrollment":977,"conditions":2500,"interventions":2501},[58],[979,980,954,981,982],[961,984,985,986,987,988,989,990,991,992,993,994,995,996,997,998,999,1000,1001,1002,1003,1004,1005,1006,1007,1008,1009,1010,1011,1012,1013,1014,1015,1016,1017,1018,1019,1020,1021,1022,1023,1024,1025,1026,1027,1028,1029,1030,1031,1032,1033,1034,1035,1036,1037,1038,1039,1040,1041,1042,1043,1044,1045,1046,1047,1048,1049,1050,1051,1052,1053,1054,1055,1056,1057,1058,1059,1060,1061,1062,1063,1064,1065,1066,1067,1068,1069,1070,1071,1072,1073,1074,1075,1076,1077,1078,1079],{"trials":2503,"activeCount":67},[],{"trials":2505,"activeCount":67},[],{"intervention":1063,"totalTrials":63,"cells":2507},{"EARLY_PHASE1":2508,"PHASE1":2510,"PHASE2":2512,"PHASE3":2514,"PHASE4":2520,"NA":2522},{"trials":2509,"activeCount":67},[],{"trials":2511,"activeCount":67},[],{"trials":2513,"activeCount":67},[],{"trials":2515,"activeCount":67},[2516],{"nctId":972,"briefTitle":973,"status":166,"phases":2517,"primaryCompletion":975,"completion":975,"start":976,"enrollment":977,"conditions":2518,"interventions":2519},[58],[979,980,954,981,982],[961,984,985,986,987,988,989,990,991,992,993,994,995,996,997,998,999,1000,1001,1002,1003,1004,1005,1006,1007,1008,1009,1010,1011,1012,1013,1014,1015,1016,1017,1018,1019,1020,1021,1022,1023,1024,1025,1026,1027,1028,1029,1030,1031,1032,1033,1034,1035,1036,1037,1038,1039,1040,1041,1042,1043,1044,1045,1046,1047,1048,1049,1050,1051,1052,1053,1054,1055,1056,1057,1058,1059,1060,1061,1062,1063,1064,1065,1066,1067,1068,1069,1070,1071,1072,1073,1074,1075,1076,1077,1078,1079],{"trials":2521,"activeCount":67},[],{"trials":2523,"activeCount":67},[],{"intervention":1064,"totalTrials":63,"cells":2525},{"EARLY_PHASE1":2526,"PHASE1":2528,"PHASE2":2530,"PHASE3":2532,"PHASE4":2538,"NA":2540},{"trials":2527,"activeCount":67},[],{"trials":2529,"activeCount":67},[],{"trials":2531,"activeCount":67},[],{"trials":2533,"activeCount":67},[2534],{"nctId":972,"briefTitle":973,"status":166,"phases":2535,"primaryCompletion":975,"completion":975,"start":976,"enrollment":977,"conditions":2536,"interventions":2537},[58],[979,980,954,981,982],[961,984,985,986,987,988,989,990,991,992,993,994,995,996,997,998,999,1000,1001,1002,1003,1004,1005,1006,1007,1008,1009,1010,1011,1012,1013,1014,1015,1016,1017,1018,1019,1020,1021,1022,1023,1024,1025,1026,1027,1028,1029,1030,1031,1032,1033,1034,1035,1036,1037,1038,1039,1040,1041,1042,1043,1044,1045,1046,1047,1048,1049,1050,1051,1052,1053,1054,1055,1056,1057,1058,1059,1060,1061,1062,1063,1064,1065,1066,1067,1068,1069,1070,1071,1072,1073,1074,1075,1076,1077,1078,1079],{"trials":2539,"activeCount":67},[],{"trials":2541,"activeCount":67},[],{"intervention":1065,"totalTrials":63,"cells":2543},{"EARLY_PHASE1":2544,"PHASE1":2546,"PHASE2":2548,"PHASE3":2550,"PHASE4":2556,"NA":2558},{"trials":2545,"activeCount":67},[],{"trials":2547,"activeCount":67},[],{"trials":2549,"activeCount":67},[],{"trials":2551,"activeCount":67},[2552],{"nctId":972,"briefTitle":973,"status":166,"phases":2553,"primaryCompletion":975,"completion":975,"start":976,"enrollment":977,"conditions":2554,"interventions":2555},[58],[979,980,954,981,982],[961,984,985,986,987,988,989,990,991,992,993,994,995,996,997,998,999,1000,1001,1002,1003,1004,1005,1006,1007,1008,1009,1010,1011,1012,1013,1014,1015,1016,1017,1018,1019,1020,1021,1022,1023,1024,1025,1026,1027,1028,1029,1030,1031,1032,1033,1034,1035,1036,1037,1038,1039,1040,1041,1042,1043,1044,1045,1046,1047,1048,1049,1050,1051,1052,1053,1054,1055,1056,1057,1058,1059,1060,1061,1062,1063,1064,1065,1066,1067,1068,1069,1070,1071,1072,1073,1074,1075,1076,1077,1078,1079],{"trials":2557,"activeCount":67},[],{"trials":2559,"activeCount":67},[],{"intervention":1066,"totalTrials":63,"cells":2561},{"EARLY_PHASE1":2562,"PHASE1":2564,"PHASE2":2566,"PHASE3":2568,"PHASE4":2574,"NA":2576},{"trials":2563,"activeCount":67},[],{"trials":2565,"activeCount":67},[],{"trials":2567,"activeCount":67},[],{"trials":2569,"activeCount":67},[2570],{"nctId":972,"briefTitle":973,"status":166,"phases":2571,"primaryCompletion":975,"completion":975,"start":976,"enrollment":977,"conditions":2572,"interventions":2573},[58],[979,980,954,981,982],[961,984,985,986,987,988,989,990,991,992,993,994,995,996,997,998,999,1000,1001,1002,1003,1004,1005,1006,1007,1008,1009,1010,1011,1012,1013,1014,1015,1016,1017,1018,1019,1020,1021,1022,1023,1024,1025,1026,1027,1028,1029,1030,1031,1032,1033,1034,1035,1036,1037,1038,1039,1040,1041,1042,1043,1044,1045,1046,1047,1048,1049,1050,1051,1052,1053,1054,1055,1056,1057,1058,1059,1060,1061,1062,1063,1064,1065,1066,1067,1068,1069,1070,1071,1072,1073,1074,1075,1076,1077,1078,1079],{"trials":2575,"activeCount":67},[],{"trials":2577,"activeCount":67},[],{"intervention":1067,"totalTrials":63,"cells":2579},{"EARLY_PHASE1":2580,"PHASE1":2582,"PHASE2":2584,"PHASE3":2586,"PHASE4":2592,"NA":2594},{"trials":2581,"activeCount":67},[],{"trials":2583,"activeCount":67},[],{"trials":2585,"activeCount":67},[],{"trials":2587,"activeCount":67},[2588],{"nctId":972,"briefTitle":973,"status":166,"phases":2589,"primaryCompletion":975,"completion":975,"start":976,"enrollment":977,"conditions":2590,"interventions":2591},[58],[979,980,954,981,982],[961,984,985,986,987,988,989,990,991,992,993,994,995,996,997,998,999,1000,1001,1002,1003,1004,1005,1006,1007,1008,1009,1010,1011,1012,1013,1014,1015,1016,1017,1018,1019,1020,1021,1022,1023,1024,1025,1026,1027,1028,1029,1030,1031,1032,1033,1034,1035,1036,1037,1038,1039,1040,1041,1042,1043,1044,1045,1046,1047,1048,1049,1050,1051,1052,1053,1054,1055,1056,1057,1058,1059,1060,1061,1062,1063,1064,1065,1066,1067,1068,1069,1070,1071,1072,1073,1074,1075,1076,1077,1078,1079],{"trials":2593,"activeCount":67},[],{"trials":2595,"activeCount":67},[],{"intervention":1068,"totalTrials":63,"cells":2597},{"EARLY_PHASE1":2598,"PHASE1":2600,"PHASE2":2602,"PHASE3":2604,"PHASE4":2610,"NA":2612},{"trials":2599,"activeCount":67},[],{"trials":2601,"activeCount":67},[],{"trials":2603,"activeCount":67},[],{"trials":2605,"activeCount":67},[2606],{"nctId":972,"briefTitle":973,"status":166,"phases":2607,"primaryCompletion":975,"completion":975,"start":976,"enrollment":977,"conditions":2608,"interventions":2609},[58],[979,980,954,981,982],[961,984,985,986,987,988,989,990,991,992,993,994,995,996,997,998,999,1000,1001,1002,1003,1004,1005,1006,1007,1008,1009,1010,1011,1012,1013,1014,1015,1016,1017,1018,1019,1020,1021,1022,1023,1024,1025,1026,1027,1028,1029,1030,1031,1032,1033,1034,1035,1036,1037,1038,1039,1040,1041,1042,1043,1044,1045,1046,1047,1048,1049,1050,1051,1052,1053,1054,1055,1056,1057,1058,1059,1060,1061,1062,1063,1064,1065,1066,1067,1068,1069,1070,1071,1072,1073,1074,1075,1076,1077,1078,1079],{"trials":2611,"activeCount":67},[],{"trials":2613,"activeCount":67},[],{"intervention":1069,"totalTrials":63,"cells":2615},{"EARLY_PHASE1":2616,"PHASE1":2618,"PHASE2":2620,"PHASE3":2622,"PHASE4":2628,"NA":2630},{"trials":2617,"activeCount":67},[],{"trials":2619,"activeCount":67},[],{"trials":2621,"activeCount":67},[],{"trials":2623,"activeCount":67},[2624],{"nctId":972,"briefTitle":973,"status":166,"phases":2625,"primaryCompletion":975,"completion":975,"start":976,"enrollment":977,"conditions":2626,"interventions":2627},[58],[979,980,954,981,982],[961,984,985,986,987,988,989,990,991,992,993,994,995,996,997,998,999,1000,1001,1002,1003,1004,1005,1006,1007,1008,1009,1010,1011,1012,1013,1014,1015,1016,1017,1018,1019,1020,1021,1022,1023,1024,1025,1026,1027,1028,1029,1030,1031,1032,1033,1034,1035,1036,1037,1038,1039,1040,1041,1042,1043,1044,1045,1046,1047,1048,1049,1050,1051,1052,1053,1054,1055,1056,1057,1058,1059,1060,1061,1062,1063,1064,1065,1066,1067,1068,1069,1070,1071,1072,1073,1074,1075,1076,1077,1078,1079],{"trials":2629,"activeCount":67},[],{"trials":2631,"activeCount":67},[],{"intervention":1070,"totalTrials":63,"cells":2633},{"EARLY_PHASE1":2634,"PHASE1":2636,"PHASE2":2638,"PHASE3":2640,"PHASE4":2646,"NA":2648},{"trials":2635,"activeCount":67},[],{"trials":2637,"activeCount":67},[],{"trials":2639,"activeCount":67},[],{"trials":2641,"activeCount":67},[2642],{"nctId":972,"briefTitle":973,"status":166,"phases":2643,"primaryCompletion":975,"completion":975,"start":976,"enrollment":977,"conditions":2644,"interventions":2645},[58],[979,980,954,981,982],[961,984,985,986,987,988,989,990,991,992,993,994,995,996,997,998,999,1000,1001,1002,1003,1004,1005,1006,1007,1008,1009,1010,1011,1012,1013,1014,1015,1016,1017,1018,1019,1020,1021,1022,1023,1024,1025,1026,1027,1028,1029,1030,1031,1032,1033,1034,1035,1036,1037,1038,1039,1040,1041,1042,1043,1044,1045,1046,1047,1048,1049,1050,1051,1052,1053,1054,1055,1056,1057,1058,1059,1060,1061,1062,1063,1064,1065,1066,1067,1068,1069,1070,1071,1072,1073,1074,1075,1076,1077,1078,1079],{"trials":2647,"activeCount":67},[],{"trials":2649,"activeCount":67},[],{"intervention":1071,"totalTrials":63,"cells":2651},{"EARLY_PHASE1":2652,"PHASE1":2654,"PHASE2":2656,"PHASE3":2658,"PHASE4":2664,"NA":2666},{"trials":2653,"activeCount":67},[],{"trials":2655,"activeCount":67},[],{"trials":2657,"activeCount":67},[],{"trials":2659,"activeCount":67},[2660],{"nctId":972,"briefTitle":973,"status":166,"phases":2661,"primaryCompletion":975,"completion":975,"start":976,"enrollment":977,"conditions":2662,"interventions":2663},[58],[979,980,954,981,982],[961,984,985,986,987,988,989,990,991,992,993,994,995,996,997,998,999,1000,1001,1002,1003,1004,1005,1006,1007,1008,1009,1010,1011,1012,1013,1014,1015,1016,1017,1018,1019,1020,1021,1022,1023,1024,1025,1026,1027,1028,1029,1030,1031,1032,1033,1034,1035,1036,1037,1038,1039,1040,1041,1042,1043,1044,1045,1046,1047,1048,1049,1050,1051,1052,1053,1054,1055,1056,1057,1058,1059,1060,1061,1062,1063,1064,1065,1066,1067,1068,1069,1070,1071,1072,1073,1074,1075,1076,1077,1078,1079],{"trials":2665,"activeCount":67},[],{"trials":2667,"activeCount":67},[],{"intervention":1072,"totalTrials":63,"cells":2669},{"EARLY_PHASE1":2670,"PHASE1":2672,"PHASE2":2674,"PHASE3":2676,"PHASE4":2682,"NA":2684},{"trials":2671,"activeCount":67},[],{"trials":2673,"activeCount":67},[],{"trials":2675,"activeCount":67},[],{"trials":2677,"activeCount":67},[2678],{"nctId":972,"briefTitle":973,"status":166,"phases":2679,"primaryCompletion":975,"completion":975,"start":976,"enrollment":977,"conditions":2680,"interventions":2681},[58],[979,980,954,981,982],[961,984,985,986,987,988,989,990,991,992,993,994,995,996,997,998,999,1000,1001,1002,1003,1004,1005,1006,1007,1008,1009,1010,1011,1012,1013,1014,1015,1016,1017,1018,1019,1020,1021,1022,1023,1024,1025,1026,1027,1028,1029,1030,1031,1032,1033,1034,1035,1036,1037,1038,1039,1040,1041,1042,1043,1044,1045,1046,1047,1048,1049,1050,1051,1052,1053,1054,1055,1056,1057,1058,1059,1060,1061,1062,1063,1064,1065,1066,1067,1068,1069,1070,1071,1072,1073,1074,1075,1076,1077,1078,1079],{"trials":2683,"activeCount":67},[],{"trials":2685,"activeCount":67},[],{"intervention":1073,"totalTrials":63,"cells":2687},{"EARLY_PHASE1":2688,"PHASE1":2690,"PHASE2":2692,"PHASE3":2694,"PHASE4":2700,"NA":2702},{"trials":2689,"activeCount":67},[],{"trials":2691,"activeCount":67},[],{"trials":2693,"activeCount":67},[],{"trials":2695,"activeCount":67},[2696],{"nctId":972,"briefTitle":973,"status":166,"phases":2697,"primaryCompletion":975,"completion":975,"start":976,"enrollment":977,"conditions":2698,"interventions":2699},[58],[979,980,954,981,982],[961,984,985,986,987,988,989,990,991,992,993,994,995,996,997,998,999,1000,1001,1002,1003,1004,1005,1006,1007,1008,1009,1010,1011,1012,1013,1014,1015,1016,1017,1018,1019,1020,1021,1022,1023,1024,1025,1026,1027,1028,1029,1030,1031,1032,1033,1034,1035,1036,1037,1038,1039,1040,1041,1042,1043,1044,1045,1046,1047,1048,1049,1050,1051,1052,1053,1054,1055,1056,1057,1058,1059,1060,1061,1062,1063,1064,1065,1066,1067,1068,1069,1070,1071,1072,1073,1074,1075,1076,1077,1078,1079],{"trials":2701,"activeCount":67},[],{"trials":2703,"activeCount":67},[],{"intervention":1074,"totalTrials":63,"cells":2705},{"EARLY_PHASE1":2706,"PHASE1":2708,"PHASE2":2710,"PHASE3":2712,"PHASE4":2718,"NA":2720},{"trials":2707,"activeCount":67},[],{"trials":2709,"activeCount":67},[],{"trials":2711,"activeCount":67},[],{"trials":2713,"activeCount":67},[2714],{"nctId":972,"briefTitle":973,"status":166,"phases":2715,"primaryCompletion":975,"completion":975,"start":976,"enrollment":977,"conditions":2716,"interventions":2717},[58],[979,980,954,981,982],[961,984,985,986,987,988,989,990,991,992,993,994,995,996,997,998,999,1000,1001,1002,1003,1004,1005,1006,1007,1008,1009,1010,1011,1012,1013,1014,1015,1016,1017,1018,1019,1020,1021,1022,1023,1024,1025,1026,1027,1028,1029,1030,1031,1032,1033,1034,1035,1036,1037,1038,1039,1040,1041,1042,1043,1044,1045,1046,1047,1048,1049,1050,1051,1052,1053,1054,1055,1056,1057,1058,1059,1060,1061,1062,1063,1064,1065,1066,1067,1068,1069,1070,1071,1072,1073,1074,1075,1076,1077,1078,1079],{"trials":2719,"activeCount":67},[],{"trials":2721,"activeCount":67},[],{"intervention":1075,"totalTrials":63,"cells":2723},{"EARLY_PHASE1":2724,"PHASE1":2726,"PHASE2":2728,"PHASE3":2730,"PHASE4":2736,"NA":2738},{"trials":2725,"activeCount":67},[],{"trials":2727,"activeCount":67},[],{"trials":2729,"activeCount":67},[],{"trials":2731,"activeCount":67},[2732],{"nctId":972,"briefTitle":973,"status":166,"phases":2733,"primaryCompletion":975,"completion":975,"start":976,"enrollment":977,"conditions":2734,"interventions":2735},[58],[979,980,954,981,982],[961,984,985,986,987,988,989,990,991,992,993,994,995,996,997,998,999,1000,1001,1002,1003,1004,1005,1006,1007,1008,1009,1010,1011,1012,1013,1014,1015,1016,1017,1018,1019,1020,1021,1022,1023,1024,1025,1026,1027,1028,1029,1030,1031,1032,1033,1034,1035,1036,1037,1038,1039,1040,1041,1042,1043,1044,1045,1046,1047,1048,1049,1050,1051,1052,1053,1054,1055,1056,1057,1058,1059,1060,1061,1062,1063,1064,1065,1066,1067,1068,1069,1070,1071,1072,1073,1074,1075,1076,1077,1078,1079],{"trials":2737,"activeCount":67},[],{"trials":2739,"activeCount":67},[],{"intervention":1076,"totalTrials":63,"cells":2741},{"EARLY_PHASE1":2742,"PHASE1":2744,"PHASE2":2746,"PHASE3":2748,"PHASE4":2754,"NA":2756},{"trials":2743,"activeCount":67},[],{"trials":2745,"activeCount":67},[],{"trials":2747,"activeCount":67},[],{"trials":2749,"activeCount":67},[2750],{"nctId":972,"briefTitle":973,"status":166,"phases":2751,"primaryCompletion":975,"completion":975,"start":976,"enrollment":977,"conditions":2752,"interventions":2753},[58],[979,980,954,981,982],[961,984,985,986,987,988,989,990,991,992,993,994,995,996,997,998,999,1000,1001,1002,1003,1004,1005,1006,1007,1008,1009,1010,1011,1012,1013,1014,1015,1016,1017,1018,1019,1020,1021,1022,1023,1024,1025,1026,1027,1028,1029,1030,1031,1032,1033,1034,1035,1036,1037,1038,1039,1040,1041,1042,1043,1044,1045,1046,1047,1048,1049,1050,1051,1052,1053,1054,1055,1056,1057,1058,1059,1060,1061,1062,1063,1064,1065,1066,1067,1068,1069,1070,1071,1072,1073,1074,1075,1076,1077,1078,1079],{"trials":2755,"activeCount":67},[],{"trials":2757,"activeCount":67},[],{"intervention":1077,"totalTrials":63,"cells":2759},{"EARLY_PHASE1":2760,"PHASE1":2762,"PHASE2":2764,"PHASE3":2766,"PHASE4":2772,"NA":2774},{"trials":2761,"activeCount":67},[],{"trials":2763,"activeCount":67},[],{"trials":2765,"activeCount":67},[],{"trials":2767,"activeCount":67},[2768],{"nctId":972,"briefTitle":973,"status":166,"phases":2769,"primaryCompletion":975,"completion":975,"start":976,"enrollment":977,"conditions":2770,"interventions":2771},[58],[979,980,954,981,982],[961,984,985,986,987,988,989,990,991,992,993,994,995,996,997,998,999,1000,1001,1002,1003,1004,1005,1006,1007,1008,1009,1010,1011,1012,1013,1014,1015,1016,1017,1018,1019,1020,1021,1022,1023,1024,1025,1026,1027,1028,1029,1030,1031,1032,1033,1034,1035,1036,1037,1038,1039,1040,1041,1042,1043,1044,1045,1046,1047,1048,1049,1050,1051,1052,1053,1054,1055,1056,1057,1058,1059,1060,1061,1062,1063,1064,1065,1066,1067,1068,1069,1070,1071,1072,1073,1074,1075,1076,1077,1078,1079],{"trials":2773,"activeCount":67},[],{"trials":2775,"activeCount":67},[],{"intervention":1078,"totalTrials":63,"cells":2777},{"EARLY_PHASE1":2778,"PHASE1":2780,"PHASE2":2782,"PHASE3":2784,"PHASE4":2790,"NA":2792},{"trials":2779,"activeCount":67},[],{"trials":2781,"activeCount":67},[],{"trials":2783,"activeCount":67},[],{"trials":2785,"activeCount":67},[2786],{"nctId":972,"briefTitle":973,"status":166,"phases":2787,"primaryCompletion":975,"completion":975,"start":976,"enrollment":977,"conditions":2788,"interventions":2789},[58],[979,980,954,981,982],[961,984,985,986,987,988,989,990,991,992,993,994,995,996,997,998,999,1000,1001,1002,1003,1004,1005,1006,1007,1008,1009,1010,1011,1012,1013,1014,1015,1016,1017,1018,1019,1020,1021,1022,1023,1024,1025,1026,1027,1028,1029,1030,1031,1032,1033,1034,1035,1036,1037,1038,1039,1040,1041,1042,1043,1044,1045,1046,1047,1048,1049,1050,1051,1052,1053,1054,1055,1056,1057,1058,1059,1060,1061,1062,1063,1064,1065,1066,1067,1068,1069,1070,1071,1072,1073,1074,1075,1076,1077,1078,1079],{"trials":2791,"activeCount":67},[],{"trials":2793,"activeCount":67},[],{"intervention":1079,"totalTrials":63,"cells":2795},{"EARLY_PHASE1":2796,"PHASE1":2798,"PHASE2":2800,"PHASE3":2802,"PHASE4":2808,"NA":2810},{"trials":2797,"activeCount":67},[],{"trials":2799,"activeCount":67},[],{"trials":2801,"activeCount":67},[],{"trials":2803,"activeCount":67},[2804],{"nctId":972,"briefTitle":973,"status":166,"phases":2805,"primaryCompletion":975,"completion":975,"start":976,"enrollment":977,"conditions":2806,"interventions":2807},[58],[979,980,954,981,982],[961,984,985,986,987,988,989,990,991,992,993,994,995,996,997,998,999,1000,1001,1002,1003,1004,1005,1006,1007,1008,1009,1010,1011,1012,1013,1014,1015,1016,1017,1018,1019,1020,1021,1022,1023,1024,1025,1026,1027,1028,1029,1030,1031,1032,1033,1034,1035,1036,1037,1038,1039,1040,1041,1042,1043,1044,1045,1046,1047,1048,1049,1050,1051,1052,1053,1054,1055,1056,1057,1058,1059,1060,1061,1062,1063,1064,1065,1066,1067,1068,1069,1070,1071,1072,1073,1074,1075,1076,1077,1078,1079],{"trials":2809,"activeCount":67},[],{"trials":2811,"activeCount":67},[],{"intervention":2813,"totalTrials":63,"cells":2814},"Hematopoietic stem cells from bone marrow or peripheral blood",{"EARLY_PHASE1":2815,"PHASE1":2817,"PHASE2":2819,"PHASE3":2821,"PHASE4":2833,"NA":2835},{"trials":2816,"activeCount":67},[],{"trials":2818,"activeCount":67},[],{"trials":2820,"activeCount":67},[],{"trials":2822,"activeCount":67},[2823],{"nctId":2824,"briefTitle":2825,"status":179,"phases":2826,"primaryCompletion":2827,"completion":2827,"start":2828,"enrollment":2829,"conditions":2830,"interventions":2832},"NCT00606723","Allogenic Stem Cell Transplantation for Children, Adolescents and Young Adults With Relapsed or Refractory AML",[58],"2021-02-24","2010-04",154,[2831],"Acute Myeloid Leukemia (AML)",[2813],{"trials":2834,"activeCount":67},[],{"trials":2836,"activeCount":67},[],{"intervention":2838,"totalTrials":63,"cells":2839},"Clofarabine, ara-C",{"EARLY_PHASE1":2840,"PHASE1":2842,"PHASE2":2844,"PHASE3":2856,"PHASE4":2858,"NA":2860},{"trials":2841,"activeCount":67},[],{"trials":2843,"activeCount":67},[],{"trials":2845,"activeCount":67},[2846],{"nctId":2847,"briefTitle":2848,"status":406,"phases":2849,"primaryCompletion":976,"start":2850,"enrollment":2851,"conditions":2852,"interventions":2854},"NCT01423175","ClAraC or FLAMSA Followed by Stem Cell Transplantation to Treat High Risk AML or Advanced MDS",[57],"2011-07",60,[25,2853],"MDS",[2838,2855],"FLAMSA",{"trials":2857,"activeCount":67},[],{"trials":2859,"activeCount":67},[],{"trials":2861,"activeCount":67},[],{"intervention":2855,"totalTrials":63,"cells":2863},{"EARLY_PHASE1":2864,"PHASE1":2866,"PHASE2":2868,"PHASE3":2874,"PHASE4":2876,"NA":2878},{"trials":2865,"activeCount":67},[],{"trials":2867,"activeCount":67},[],{"trials":2869,"activeCount":67},[2870],{"nctId":2847,"briefTitle":2848,"status":406,"phases":2871,"primaryCompletion":976,"start":2850,"enrollment":2851,"conditions":2872,"interventions":2873},[57],[25,2853],[2838,2855],{"trials":2875,"activeCount":67},[],{"trials":2877,"activeCount":67},[],{"trials":2879,"activeCount":67},[],{"intervention":2881,"totalTrials":63,"cells":2882},"clofarabine, cytarabine, idarubicin",{"EARLY_PHASE1":2883,"PHASE1":2885,"PHASE2":2887,"PHASE3":2898,"PHASE4":2900,"NA":2902},{"trials":2884,"activeCount":67},[],{"trials":2886,"activeCount":67},[],{"trials":2888,"activeCount":67},[2889],{"nctId":2890,"briefTitle":2891,"status":406,"phases":2892,"primaryCompletion":2893,"completion":2894,"start":2895,"enrollment":2851,"conditions":2896,"interventions":2897},"NCT01534702","Dose Escalation of Clofarabine in Combination With Cytarabine and Idarubicin as Induction Therapy in High Risk AML",[56,57],"2013-04","2015-09","2012-01",[25],[2881],{"trials":2899,"activeCount":67},[],{"trials":2901,"activeCount":67},[],{"trials":2903,"activeCount":67},[],{"intervention":2905,"totalTrials":63,"cells":2906},"Polidocanol",{"EARLY_PHASE1":2907,"PHASE1":2909,"PHASE2":2911,"PHASE3":2925,"PHASE4":2927,"NA":2929},{"trials":2908,"activeCount":67},[],{"trials":2910,"activeCount":67},[],{"trials":2912,"activeCount":67},[2913],{"nctId":2914,"briefTitle":2915,"status":406,"phases":2916,"primaryCompletion":951,"completion":2917,"start":2918,"enrollment":2919,"conditions":2920,"interventions":2923},"NCT01185951","TENDOSHOCK-2010 Combination Therapy for Athletic Tendinopathies",[57],"2010-12","2007-01",114,[2921,2922],"Tendinopathy","Epicondylitis",[2905,2924],"Topical NO",{"trials":2926,"activeCount":67},[],{"trials":2928,"activeCount":67},[],{"trials":2930,"activeCount":67},[],{"intervention":2924,"totalTrials":63,"cells":2932},{"EARLY_PHASE1":2933,"PHASE1":2935,"PHASE2":2937,"PHASE3":2943,"PHASE4":2945,"NA":2947},{"trials":2934,"activeCount":67},[],{"trials":2936,"activeCount":67},[],{"trials":2938,"activeCount":67},[2939],{"nctId":2914,"briefTitle":2915,"status":406,"phases":2940,"primaryCompletion":951,"completion":2917,"start":2918,"enrollment":2919,"conditions":2941,"interventions":2942},[57],[2921,2922],[2905,2924],{"trials":2944,"activeCount":67},[],{"trials":2946,"activeCount":67},[],{"trials":2948,"activeCount":67},[],{"intervention":2950,"totalTrials":63,"cells":2951},"Cisplatin, Gemcitabine, Panitumumab",{"EARLY_PHASE1":2952,"PHASE1":2954,"PHASE2":2956,"PHASE3":2969,"PHASE4":2971,"NA":2973},{"trials":2953,"activeCount":67},[],{"trials":2955,"activeCount":67},[],{"trials":2957,"activeCount":67},[2958],{"nctId":2959,"briefTitle":2960,"status":179,"phases":2961,"primaryCompletion":2962,"completion":2962,"start":2963,"enrollment":2964,"conditions":2965,"interventions":2967},"NCT01320254","PiCCA Study (Panitumumab in Combination With Cisplatin\u002FGemcitabine)",[57],"2016-09-12","2011-06",93,[2966],"Cholangiocarcinomas",[2950,2968],"Cisplatin, Gemcitabine",{"trials":2970,"activeCount":67},[],{"trials":2972,"activeCount":67},[],{"trials":2974,"activeCount":67},[],{"intervention":2968,"totalTrials":63,"cells":2976},{"EARLY_PHASE1":2977,"PHASE1":2979,"PHASE2":2981,"PHASE3":2987,"PHASE4":2989,"NA":2991},{"trials":2978,"activeCount":67},[],{"trials":2980,"activeCount":67},[],{"trials":2982,"activeCount":67},[2983],{"nctId":2959,"briefTitle":2960,"status":179,"phases":2984,"primaryCompletion":2962,"completion":2962,"start":2963,"enrollment":2964,"conditions":2985,"interventions":2986},[57],[2966],[2950,2968],{"trials":2988,"activeCount":67},[],{"trials":2990,"activeCount":67},[],{"trials":2992,"activeCount":67},[],{"intervention":2994,"totalTrials":63,"cells":2995},"Bromocriptine",{"EARLY_PHASE1":2996,"PHASE1":2998,"PHASE2":3000,"PHASE3":3013,"PHASE4":3015,"NA":3017},{"trials":2997,"activeCount":67},[],{"trials":2999,"activeCount":67},[],{"trials":3001,"activeCount":67},[3002],{"nctId":3003,"briefTitle":3004,"status":179,"phases":3005,"primaryCompletion":3006,"completion":3007,"start":3008,"enrollment":3009,"conditions":3010,"interventions":3012},"NCT00998556","Effect of Bromocriptine on Left Ventricular Function in Women With Peripartum Cardiomyopathy",[57],"2016-03","2016-08","2010-06",64,[3011],"Peripartum Cardiomyopathy",[2994],{"trials":3014,"activeCount":67},[],{"trials":3016,"activeCount":67},[],{"trials":3018,"activeCount":67},[],{"intervention":3020,"totalTrials":63,"cells":3021},"beta-blocker",{"EARLY_PHASE1":3022,"PHASE1":3024,"PHASE2":3026,"PHASE3":3036,"PHASE4":3038,"NA":3040},{"trials":3023,"activeCount":67},[],{"trials":3025,"activeCount":67},[],{"trials":3027,"activeCount":67},[3028],{"nctId":3029,"briefTitle":3030,"status":406,"phases":3031,"primaryCompletion":649,"completion":2917,"start":279,"enrollment":482,"conditions":3032,"interventions":3034},"NCT00865917","Cardiovascular Effects of Selective I(f)-Channel Blockade",[57],[3033],"Postural Orthostatic Tachycardia Syndrome",[3020,3035],"I",{"trials":3037,"activeCount":67},[],{"trials":3039,"activeCount":67},[],{"trials":3041,"activeCount":67},[],{"intervention":3035,"totalTrials":63,"cells":3043},{"EARLY_PHASE1":3044,"PHASE1":3046,"PHASE2":3048,"PHASE3":3054,"PHASE4":3056,"NA":3058},{"trials":3045,"activeCount":67},[],{"trials":3047,"activeCount":67},[],{"trials":3049,"activeCount":67},[3050],{"nctId":3029,"briefTitle":3030,"status":406,"phases":3051,"primaryCompletion":649,"completion":2917,"start":279,"enrollment":482,"conditions":3052,"interventions":3053},[57],[3033],[3020,3035],{"trials":3055,"activeCount":67},[],{"trials":3057,"activeCount":67},[],{"trials":3059,"activeCount":67},[],{"intervention":3061,"totalTrials":63,"cells":3062},"sacubitril+valsartan",{"EARLY_PHASE1":3063,"PHASE1":3065,"PHASE2":3067,"PHASE3":3079,"PHASE4":3081,"NA":3083},{"trials":3064,"activeCount":67},[],{"trials":3066,"activeCount":67},[],{"trials":3068,"activeCount":67},[3069],{"nctId":3070,"briefTitle":3071,"status":3072,"phases":3073,"primaryCompletion":3074,"completion":3074,"start":3075,"enrollment":67,"conditions":3076,"interventions":3077},"NCT03415906","Influences of Angiotensin-neprilysin Inhibition on Sympathetic Activity in Heart Failure","WITHDRAWN",[57],"2018-09-06","2017-12-14",[18],[3061,3078],"valsartan",{"trials":3080,"activeCount":67},[],{"trials":3082,"activeCount":67},[],{"trials":3084,"activeCount":67},[],{"intervention":3078,"totalTrials":63,"cells":3086},{"EARLY_PHASE1":3087,"PHASE1":3089,"PHASE2":3091,"PHASE3":3097,"PHASE4":3099,"NA":3101},{"trials":3088,"activeCount":67},[],{"trials":3090,"activeCount":67},[],{"trials":3092,"activeCount":67},[3093],{"nctId":3070,"briefTitle":3071,"status":3072,"phases":3094,"primaryCompletion":3074,"completion":3074,"start":3075,"enrollment":67,"conditions":3095,"interventions":3096},[57],[18],[3061,3078],{"trials":3098,"activeCount":67},[],{"trials":3100,"activeCount":67},[],{"trials":3102,"activeCount":67},[],{"intervention":3104,"totalTrials":63,"cells":3105},"Human hepatitis B Immunoglobulin",{"EARLY_PHASE1":3106,"PHASE1":3108,"PHASE2":3110,"PHASE3":3121,"PHASE4":3123,"NA":3125},{"trials":3107,"activeCount":67},[],{"trials":3109,"activeCount":67},[],{"trials":3111,"activeCount":67},[3112],{"nctId":3113,"briefTitle":3114,"status":166,"phases":3115,"primaryCompletion":3116,"completion":3116,"start":3117,"enrollment":903,"conditions":3118,"interventions":3120},"NCT05345990","Treatment of Patients With Chronic Hepatitis B With Hepatitis B Immunoglobulins",[57],"2025-07-31","2022-08-15",[3119],"Chronic Hepatitis B",[3104],{"trials":3122,"activeCount":67},[],{"trials":3124,"activeCount":67},[],{"trials":3126,"activeCount":67},[],{"intervention":3128,"totalTrials":63,"cells":3129},"Temsirolimus",{"EARLY_PHASE1":3130,"PHASE1":3132,"PHASE2":3134,"PHASE3":3144,"PHASE4":3146,"NA":3148},{"trials":3131,"activeCount":67},[],{"trials":3133,"activeCount":67},[],{"trials":3135,"activeCount":67},[3136],{"nctId":3137,"briefTitle":3138,"status":179,"phases":3139,"primaryCompletion":278,"completion":278,"start":3008,"enrollment":3140,"conditions":3141,"interventions":3143},"NCT01172769","Efficacy Study of Temsirolimus to Treat Head and Neck Cancer",[57],42,[3142],"Head and Neck Squamous Cell Carcinoma",[3128],{"trials":3145,"activeCount":67},[],{"trials":3147,"activeCount":67},[],{"trials":3149,"activeCount":67},[],{"intervention":556,"totalTrials":63,"cells":3151},{"EARLY_PHASE1":3152,"PHASE1":3154,"PHASE2":3156,"PHASE3":3162,"PHASE4":3164,"NA":3166},{"trials":3153,"activeCount":67},[],{"trials":3155,"activeCount":67},[],{"trials":3157,"activeCount":67},[3158],{"nctId":549,"briefTitle":550,"status":406,"phases":3159,"start":552,"conditions":3160,"interventions":3161},[57],[554],[556,557,558,559,560,561,562,563,564,565,566,567],{"trials":3163,"activeCount":67},[],{"trials":3165,"activeCount":67},[],{"trials":3167,"activeCount":67},[],{"intervention":557,"totalTrials":63,"cells":3169},{"EARLY_PHASE1":3170,"PHASE1":3172,"PHASE2":3174,"PHASE3":3180,"PHASE4":3182,"NA":3184},{"trials":3171,"activeCount":67},[],{"trials":3173,"activeCount":67},[],{"trials":3175,"activeCount":67},[3176],{"nctId":549,"briefTitle":550,"status":406,"phases":3177,"start":552,"conditions":3178,"interventions":3179},[57],[554],[556,557,558,559,560,561,562,563,564,565,566,567],{"trials":3181,"activeCount":67},[],{"trials":3183,"activeCount":67},[],{"trials":3185,"activeCount":67},[],{"intervention":559,"totalTrials":63,"cells":3187},{"EARLY_PHASE1":3188,"PHASE1":3190,"PHASE2":3192,"PHASE3":3198,"PHASE4":3200,"NA":3202},{"trials":3189,"activeCount":67},[],{"trials":3191,"activeCount":67},[],{"trials":3193,"activeCount":67},[3194],{"nctId":549,"briefTitle":550,"status":406,"phases":3195,"start":552,"conditions":3196,"interventions":3197},[57],[554],[556,557,558,559,560,561,562,563,564,565,566,567],{"trials":3199,"activeCount":67},[],{"trials":3201,"activeCount":67},[],{"trials":3203,"activeCount":67},[],{"intervention":560,"totalTrials":63,"cells":3205},{"EARLY_PHASE1":3206,"PHASE1":3208,"PHASE2":3210,"PHASE3":3216,"PHASE4":3218,"NA":3220},{"trials":3207,"activeCount":67},[],{"trials":3209,"activeCount":67},[],{"trials":3211,"activeCount":67},[3212],{"nctId":549,"briefTitle":550,"status":406,"phases":3213,"start":552,"conditions":3214,"interventions":3215},[57],[554],[556,557,558,559,560,561,562,563,564,565,566,567],{"trials":3217,"activeCount":67},[],{"trials":3219,"activeCount":67},[],{"trials":3221,"activeCount":67},[],{"intervention":563,"totalTrials":63,"cells":3223},{"EARLY_PHASE1":3224,"PHASE1":3226,"PHASE2":3228,"PHASE3":3234,"PHASE4":3236,"NA":3238},{"trials":3225,"activeCount":67},[],{"trials":3227,"activeCount":67},[],{"trials":3229,"activeCount":67},[3230],{"nctId":549,"briefTitle":550,"status":406,"phases":3231,"start":552,"conditions":3232,"interventions":3233},[57],[554],[556,557,558,559,560,561,562,563,564,565,566,567],{"trials":3235,"activeCount":67},[],{"trials":3237,"activeCount":67},[],{"trials":3239,"activeCount":67},[],{"intervention":564,"totalTrials":63,"cells":3241},{"EARLY_PHASE1":3242,"PHASE1":3244,"PHASE2":3246,"PHASE3":3252,"PHASE4":3254,"NA":3256},{"trials":3243,"activeCount":67},[],{"trials":3245,"activeCount":67},[],{"trials":3247,"activeCount":67},[3248],{"nctId":549,"briefTitle":550,"status":406,"phases":3249,"start":552,"conditions":3250,"interventions":3251},[57],[554],[556,557,558,559,560,561,562,563,564,565,566,567],{"trials":3253,"activeCount":67},[],{"trials":3255,"activeCount":67},[],{"trials":3257,"activeCount":67},[],{"intervention":565,"totalTrials":63,"cells":3259},{"EARLY_PHASE1":3260,"PHASE1":3262,"PHASE2":3264,"PHASE3":3270,"PHASE4":3272,"NA":3274},{"trials":3261,"activeCount":67},[],{"trials":3263,"activeCount":67},[],{"trials":3265,"activeCount":67},[3266],{"nctId":549,"briefTitle":550,"status":406,"phases":3267,"start":552,"conditions":3268,"interventions":3269},[57],[554],[556,557,558,559,560,561,562,563,564,565,566,567],{"trials":3271,"activeCount":67},[],{"trials":3273,"activeCount":67},[],{"trials":3275,"activeCount":67},[],{"intervention":566,"totalTrials":63,"cells":3277},{"EARLY_PHASE1":3278,"PHASE1":3280,"PHASE2":3282,"PHASE3":3288,"PHASE4":3290,"NA":3292},{"trials":3279,"activeCount":67},[],{"trials":3281,"activeCount":67},[],{"trials":3283,"activeCount":67},[3284],{"nctId":549,"briefTitle":550,"status":406,"phases":3285,"start":552,"conditions":3286,"interventions":3287},[57],[554],[556,557,558,559,560,561,562,563,564,565,566,567],{"trials":3289,"activeCount":67},[],{"trials":3291,"activeCount":67},[],{"trials":3293,"activeCount":67},[],{"intervention":567,"totalTrials":63,"cells":3295},{"EARLY_PHASE1":3296,"PHASE1":3298,"PHASE2":3300,"PHASE3":3306,"PHASE4":3308,"NA":3310},{"trials":3297,"activeCount":67},[],{"trials":3299,"activeCount":67},[],{"trials":3301,"activeCount":67},[3302],{"nctId":549,"briefTitle":550,"status":406,"phases":3303,"start":552,"conditions":3304,"interventions":3305},[57],[554],[556,557,558,559,560,561,562,563,564,565,566,567],{"trials":3307,"activeCount":67},[],{"trials":3309,"activeCount":67},[],{"trials":3311,"activeCount":67},[],{"intervention":3313,"totalTrials":63,"cells":3314},"incobotulinumtoxin A",{"EARLY_PHASE1":3315,"PHASE1":3317,"PHASE2":3319,"PHASE3":3332,"PHASE4":3334,"NA":3336},{"trials":3316,"activeCount":67},[],{"trials":3318,"activeCount":67},[],{"trials":3320,"activeCount":67},[3321],{"nctId":3322,"briefTitle":3323,"status":179,"phases":3324,"primaryCompletion":3325,"completion":3326,"start":3327,"enrollment":3328,"conditions":3329,"interventions":3331},"NCT02728778","Botulinum Toxin A for Emotional Stabilization in Borderline Personality Disorder (BPD)",[57],"2019-04-30","2019-10-31","2016-09-01",54,[3330],"Borderline Personality Disorder",[3313],{"trials":3333,"activeCount":67},[],{"trials":3335,"activeCount":67},[],{"trials":3337,"activeCount":67},[],{"intervention":3339,"totalTrials":63,"cells":3340},"Sofosbuvir and Velpatasvir",{"EARLY_PHASE1":3341,"PHASE1":3343,"PHASE2":3345,"PHASE3":3358,"PHASE4":3360,"NA":3362},{"trials":3342,"activeCount":67},[],{"trials":3344,"activeCount":67},[],{"trials":3346,"activeCount":67},[3347],{"nctId":3348,"briefTitle":3349,"status":179,"phases":3350,"primaryCompletion":3351,"completion":3351,"start":3352,"enrollment":3353,"conditions":3354,"interventions":3357},"NCT03818308","Trial for the Treatment of Acute Hepatitis C for 8 Weeks With Sofosbuvir\u002FVelpatasvir",[57],"2021-06-08","2019-05-28",20,[3355,3356],"Hepatitis C","Acute Hepatitis C",[3339],{"trials":3359,"activeCount":67},[],{"trials":3361,"activeCount":67},[],{"trials":3363,"activeCount":67},[],{"intervention":3365,"totalTrials":63,"cells":3366},"Pazopanib",{"EARLY_PHASE1":3367,"PHASE1":3369,"PHASE2":3371,"PHASE3":3384,"PHASE4":3386,"NA":3388},{"trials":3368,"activeCount":67},[],{"trials":3370,"activeCount":67},[],{"trials":3372,"activeCount":67},[3373],{"nctId":3374,"briefTitle":3375,"status":179,"phases":3376,"primaryCompletion":3377,"completion":3377,"start":3378,"enrollment":3379,"conditions":3380,"interventions":3382},"NCT01861951","A Trial Comparing Two Medications as First Treatment in Elderly Patients With Metastatic or Advanced Soft Tissue Sarcoma",[57],"2017-07-11","2012-10",120,[3381],"Soft Tissue Sarcoma",[3365,3383],"Doxorubicin",{"trials":3385,"activeCount":67},[],{"trials":3387,"activeCount":67},[],{"trials":3389,"activeCount":67},[],{"intervention":3383,"totalTrials":63,"cells":3391},{"EARLY_PHASE1":3392,"PHASE1":3394,"PHASE2":3396,"PHASE3":3402,"PHASE4":3404,"NA":3406},{"trials":3393,"activeCount":67},[],{"trials":3395,"activeCount":67},[],{"trials":3397,"activeCount":67},[3398],{"nctId":3374,"briefTitle":3375,"status":179,"phases":3399,"primaryCompletion":3377,"completion":3377,"start":3378,"enrollment":3379,"conditions":3400,"interventions":3401},[57],[3381],[3365,3383],{"trials":3403,"activeCount":67},[],{"trials":3405,"activeCount":67},[],{"trials":3407,"activeCount":67},[],{"intervention":3409,"totalTrials":63,"cells":3410},"Sofosbuvir",{"EARLY_PHASE1":3411,"PHASE1":3413,"PHASE2":3415,"PHASE3":3429,"PHASE4":3431,"NA":3433},{"trials":3412,"activeCount":67},[],{"trials":3414,"activeCount":67},[],{"trials":3416,"activeCount":67},[3417],{"nctId":3418,"briefTitle":3419,"status":179,"phases":3420,"primaryCompletion":3421,"completion":3422,"start":3423,"enrollment":3424,"conditions":3425,"interventions":3428},"NCT03282474","HepNet Pilot Trial: Multicenter Trial for the Treatment of Chronic Hepatitis E With Sofosbuvir (SofE)",[57],"2018-11-26","2019-02-18","2017-12-07",10,[3426,3427],"Hepatitis E","Hepatitis Chronic Viral",[3409],{"trials":3430,"activeCount":67},[],{"trials":3432,"activeCount":67},[],{"trials":3434,"activeCount":67},[],{"intervention":3436,"totalTrials":63,"cells":3437},"Somatropin",{"EARLY_PHASE1":3438,"PHASE1":3440,"PHASE2":3451,"PHASE3":3453,"PHASE4":3455,"NA":3457},{"trials":3439,"activeCount":67},[],{"trials":3441,"activeCount":67},[3442],{"nctId":3443,"briefTitle":3444,"status":179,"phases":3445,"completion":3446,"start":3447,"enrollment":16,"conditions":3448,"interventions":3450},"NCT00470002","Effects of Growth Hormone on the Nitric Oxide Pathway",[56],"2005-01","2004-05",[3449],"Cardiovascular Disease",[3436],{"trials":3452,"activeCount":67},[],{"trials":3454,"activeCount":67},[],{"trials":3456,"activeCount":67},[],{"trials":3458,"activeCount":67},[],{"intervention":3460,"totalTrials":63,"cells":3461},"MVA-SARS-2-ST",{"EARLY_PHASE1":3462,"PHASE1":3464,"PHASE2":3475,"PHASE3":3477,"PHASE4":3479,"NA":3481},{"trials":3463,"activeCount":67},[],{"trials":3465,"activeCount":67},[3466],{"nctId":3467,"briefTitle":3468,"status":166,"phases":3469,"primaryCompletion":3470,"completion":3470,"start":3471,"enrollment":98,"conditions":3472,"interventions":3474},"NCT05226390","Safety, Reactogenicity and Immunogenicity of a Novel MVA-SARS-2-ST Vaccine Candidate",[56],"2023-11-21","2022-02-24",[3473],"COVID-19 Vaccines",[3460],{"trials":3476,"activeCount":67},[],{"trials":3478,"activeCount":67},[],{"trials":3480,"activeCount":67},[],{"trials":3482,"activeCount":67},[],{"intervention":3484,"totalTrials":200,"cells":3485},"Mycophenolatmofetile",{"EARLY_PHASE1":3486,"PHASE1":3488,"PHASE2":3490,"PHASE3":3492,"PHASE4":3494,"NA":3496},{"trials":3487,"activeCount":67},[],{"trials":3489,"activeCount":67},[],{"trials":3491,"activeCount":67},[],{"trials":3493,"activeCount":67},[],{"trials":3495,"activeCount":67},[],{"trials":3497,"activeCount":67},[3498,3508],{"nctId":3499,"briefTitle":3500,"status":179,"phases":3501,"primaryCompletion":3502,"completion":3502,"start":3503,"enrollment":482,"conditions":3504,"interventions":3505},"NCT00359658","Withdrawal of Steroids, Cyclosporine A Dose Reduction and Switch to Mycophenolatmofetile After Heart Transplantation",[60],"2008-06","2004-11",[23],[3506,3484,3507],"prednisolon","Cyclosporin A",{"nctId":3509,"briefTitle":3510,"status":179,"phases":3511,"primaryCompletion":3502,"completion":3502,"start":3503,"enrollment":98,"conditions":3512,"interventions":3513},"NCT00359814","Exchange of Azathioprine by Mycophenolatmofetile and Cyclosporine A Dose Reduction After Heart Transplantation",[60],[23],[3484,3507],{"intervention":3507,"totalTrials":200,"cells":3515},{"EARLY_PHASE1":3516,"PHASE1":3518,"PHASE2":3520,"PHASE3":3522,"PHASE4":3524,"NA":3526},{"trials":3517,"activeCount":67},[],{"trials":3519,"activeCount":67},[],{"trials":3521,"activeCount":67},[],{"trials":3523,"activeCount":67},[],{"trials":3525,"activeCount":67},[],{"trials":3527,"activeCount":67},[3528,3532],{"nctId":3499,"briefTitle":3500,"status":179,"phases":3529,"primaryCompletion":3502,"completion":3502,"start":3503,"enrollment":482,"conditions":3530,"interventions":3531},[60],[23],[3506,3484,3507],{"nctId":3509,"briefTitle":3510,"status":179,"phases":3533,"primaryCompletion":3502,"completion":3502,"start":3503,"enrollment":98,"conditions":3534,"interventions":3535},[60],[23],[3484,3507],{"intervention":3537,"totalTrials":63,"cells":3538},"Meropenem",{"EARLY_PHASE1":3539,"PHASE1":3541,"PHASE2":3543,"PHASE3":3545,"PHASE4":3547,"NA":3549},{"trials":3540,"activeCount":67},[],{"trials":3542,"activeCount":67},[],{"trials":3544,"activeCount":67},[],{"trials":3546,"activeCount":67},[],{"trials":3548,"activeCount":67},[],{"trials":3550,"activeCount":67},[3551],{"nctId":3552,"briefTitle":3553,"status":406,"phases":3554,"primaryCompletion":3555,"completion":3556,"start":3557,"enrollment":3558,"conditions":3559,"interventions":3561},"NCT03571711","Meropenem Pharmacokinetics in Spontaneous Bacterial Peritonitis",[],"2020-07-01","2021-01-01","2018-06-28",15,[3560,21],"Peritonitis Bacterial",[3537],{"intervention":3563,"totalTrials":63,"cells":3564},"Platelet-Rich Plasma",{"EARLY_PHASE1":3565,"PHASE1":3567,"PHASE2":3569,"PHASE3":3571,"PHASE4":3573,"NA":3575},{"trials":3566,"activeCount":67},[],{"trials":3568,"activeCount":67},[],{"trials":3570,"activeCount":67},[],{"trials":3572,"activeCount":67},[],{"trials":3574,"activeCount":67},[],{"trials":3576,"activeCount":67},[3577],{"nctId":3578,"briefTitle":3579,"status":179,"phases":3580,"primaryCompletion":3581,"completion":3582,"start":3583,"enrollment":19,"conditions":3584,"interventions":3586},"NCT03667638","Influence of Platelet Concentrates on Wound Healing",[60],"2017-11","2017-12","2016-11",[3563,3585],"Wound Healing Delayed",[3563],{"intervention":3506,"totalTrials":63,"cells":3588},{"EARLY_PHASE1":3589,"PHASE1":3591,"PHASE2":3593,"PHASE3":3595,"PHASE4":3597,"NA":3599},{"trials":3590,"activeCount":67},[],{"trials":3592,"activeCount":67},[],{"trials":3594,"activeCount":67},[],{"trials":3596,"activeCount":67},[],{"trials":3598,"activeCount":67},[],{"trials":3600,"activeCount":67},[3601],{"nctId":3499,"briefTitle":3500,"status":179,"phases":3602,"primaryCompletion":3502,"completion":3502,"start":3503,"enrollment":482,"conditions":3603,"interventions":3604},[60],[23],[3506,3484,3507],{"intervention":3606,"totalTrials":63,"cells":3607},"Lumacaftor plus Ivacaftor",{"EARLY_PHASE1":3608,"PHASE1":3610,"PHASE2":3612,"PHASE3":3614,"PHASE4":3616,"NA":3618},{"trials":3609,"activeCount":67},[],{"trials":3611,"activeCount":67},[],{"trials":3613,"activeCount":67},[],{"trials":3615,"activeCount":67},[],{"trials":3617,"activeCount":67},[],{"trials":3619,"activeCount":67},[3620],{"nctId":3621,"briefTitle":3622,"status":179,"phases":3623,"primaryCompletion":3624,"completion":3625,"start":3626,"enrollment":3627,"conditions":3628,"interventions":3630},"NCT02807415","ICM to Evaluate the Activation of p.Phe508del-CFTR by Lumacaftor in Combination With Ivacaftor",[],"2019-12-31","2020-02-10","2016-06-01",104,[3629],"Cystic Fibrosis",[3606],{"intervention":3632,"totalTrials":63,"cells":3633},"Venetoclax",{"EARLY_PHASE1":3634,"PHASE1":3636,"PHASE2":3638,"PHASE3":3640,"PHASE4":3642,"NA":3644},{"trials":3635,"activeCount":67},[],{"trials":3637,"activeCount":67},[],{"trials":3639,"activeCount":67},[],{"trials":3641,"activeCount":67},[],{"trials":3643,"activeCount":67},[],{"trials":3645,"activeCount":67},[3646],{"nctId":3647,"briefTitle":3648,"status":406,"phases":3649,"primaryCompletion":3650,"completion":3651,"start":3652,"enrollment":3653,"conditions":3654,"interventions":3655},"NCT03662724","Venetoclax Registry",[],"2021-11-01","2025-11-01","2017-11-01",100,[25],[3632],{"intervention":3657,"totalTrials":63,"cells":3658},"MMF",{"EARLY_PHASE1":3659,"PHASE1":3661,"PHASE2":3663,"PHASE3":3665,"PHASE4":3667,"NA":3669},{"trials":3660,"activeCount":67},[],{"trials":3662,"activeCount":67},[],{"trials":3664,"activeCount":67},[],{"trials":3666,"activeCount":67},[],{"trials":3668,"activeCount":67},[],{"trials":3670,"activeCount":67},[3671],{"nctId":3672,"briefTitle":3673,"status":179,"phases":3674,"primaryCompletion":3675,"completion":3675,"start":3503,"enrollment":650,"conditions":3676,"interventions":3679},"NCT00367146","MMF After Pediatric Liver Transplantation",[60],"2008-08",[3677,3678],"Liver Transplantation","Chronic Kidney Disease",[3657],{"intervention":3681,"totalTrials":63,"cells":3682},"Prostavasin",{"EARLY_PHASE1":3683,"PHASE1":3685,"PHASE2":3687,"PHASE3":3689,"PHASE4":3691,"NA":3693},{"trials":3684,"activeCount":67},[],{"trials":3686,"activeCount":67},[],{"trials":3688,"activeCount":67},[],{"trials":3690,"activeCount":67},[],{"trials":3692,"activeCount":67},[],{"trials":3694,"activeCount":67},[3695],{"nctId":3696,"briefTitle":3697,"status":179,"phases":3698,"primaryCompletion":3699,"completion":3700,"start":3701,"enrollment":3140,"conditions":3702,"interventions":3704},"NCT04235634","Intra-arterial Prostaglandin Therapy in Non-occlusive Mesenteric Ischemia",[],"2021-12-31","2022-02-01","2018-10-01",[3703],"Non-Occlusive Mesenteric Ischaemia (NOMI)",[3681],{"intervention":3706,"totalTrials":63,"cells":3707},"Propranolol",{"EARLY_PHASE1":3708,"PHASE1":3710,"PHASE2":3712,"PHASE3":3714,"PHASE4":3716,"NA":3718},{"trials":3709,"activeCount":67},[],{"trials":3711,"activeCount":67},[],{"trials":3713,"activeCount":67},[],{"trials":3715,"activeCount":67},[],{"trials":3717,"activeCount":67},[],{"trials":3719,"activeCount":67},[3720],{"nctId":3721,"briefTitle":3722,"status":179,"phases":3723,"primaryCompletion":3724,"completion":3724,"start":3675,"enrollment":3725,"conditions":3726,"interventions":3728},"NCT01211080","Off Label Use of Propranolol for Infancy Hemangiomas",[],"2013-10",72,[3727],"Hemangioma",[3706],{"intervention":3730,"totalTrials":63,"cells":3731},"Tozinameran",{"EARLY_PHASE1":3732,"PHASE1":3734,"PHASE2":3736,"PHASE3":3738,"PHASE4":3740,"NA":3742},{"trials":3733,"activeCount":67},[],{"trials":3735,"activeCount":67},[],{"trials":3737,"activeCount":67},[],{"trials":3739,"activeCount":67},[],{"trials":3741,"activeCount":67},[],{"trials":3743,"activeCount":67},[3744],{"nctId":3745,"briefTitle":3746,"status":406,"phases":3747,"primaryCompletion":3748,"completion":3749,"start":3750,"enrollment":3751,"conditions":3752,"interventions":3756},"NCT05429047","Priming of the NEonatal Immune System by Transfer of Maternal Immunity",[],"2023-04-01","2023-12-01","2022-06-07",560,[3753,3754,3755],"COVID-19","Maternal Vaccine Exposure","Respiratory Infections in Children",[3730],{"intervention":3758,"totalTrials":63,"cells":3759},"Mepolizumab",{"EARLY_PHASE1":3760,"PHASE1":3762,"PHASE2":3764,"PHASE3":3766,"PHASE4":3768,"NA":3770},{"trials":3761,"activeCount":67},[],{"trials":3763,"activeCount":67},[],{"trials":3765,"activeCount":67},[],{"trials":3767,"activeCount":67},[],{"trials":3769,"activeCount":67},[],{"trials":3771,"activeCount":67},[3772],{"nctId":3773,"briefTitle":3774,"status":406,"phases":3775,"primaryCompletion":3776,"completion":3777,"start":3778,"enrollment":482,"conditions":3779,"interventions":3781},"NCT04512521","Functional Lung MRI for Early Treatment Response Assessment for Patients With Eosinophilic Asthma",[],"2025-02","2025-08","2020-05-04",[3780],"Asthma; Eosinophilic",[3758]]